Document:

<PAGE>

                                                                    Exhibit 4.35

                                  $300,000,000

                          AmerisourceBergen Corporation

                          7 1/4% Senior Notes due 2012

                               PURCHASE AGREEMENT

                                                               November 12, 2002

Credit Suisse First Boston Corporation
Banc of America Securities LLC
J.P. Morgan Securities Inc.
As Representatives of the several Purchasers,
    c/o Credit Suisse First Boston Corporation
        Eleven Madison Avenue
        New York, N.Y. 10010-3629

Dear Sirs:

         1. Introductory. AmerisourceBergen Corporation, a Delaware corporation
(the "Company"), proposes, subject to the terms and conditions stated herein, to
issue and sell to the several initial purchasers named in Schedule A hereto (the
"Purchasers") U.S. $300,000,000 principal amount of its 7 1/4% Senior Notes due
2012 (the "Offered Securities"), to be issued under an indenture, dated as of
November 18, 2002 (the "Indenture"), among the Company, each of the subsidiary
guarantors named in Schedule D hereto (the "Guarantors") and J.P. Morgan Trust
Company, National Association, as Trustee. The Offered Securities will be
guaranteed by each of the Guarantors, who will enter into a notation of
guarantee (each, a "Notation of Guarantee" and together, the "Subsidiary
Guarantees") pursuant to the terms of the Indenture. As a result of the
Subsidiary Guarantees, the Offered Securities will be unconditionally guaranteed
on a senior unsecured basis as to payment of principal, premium, if any,
liquidated damages, if any, and interest by each of the Guarantors. The United
States Securities Act of 1933 is herein referred to as the "Securities Act."

         Holders (including subsequent transferees) of the Offered Securities
will have the registration rights set forth in the registration rights agreement
(the "Registration Rights Agreement"), to be dated the Closing Date, in
substantially the form of Exhibit I hereto, for so long as such Offered
Securities constitute "Transfer Restricted Securities" (as defined in the
Registration Rights Agreement). Pursuant to the Registration Rights Agreement,
the Company and the Guarantors will agree to file with the Securities and
Exchange Commission (the "Commission") under the circumstances set forth
therein, (i) a registration statement under the Securities Act (the "Exchange
Offer Registration Statement") relating to the Company's 7 1/4% Senior Notes due
2012 (the "Exchange Securities"), in a like aggregate principal amount as the
Company issued under the Indenture

<PAGE>

and guarantees thereof by the Guarantors (the "Exchange Security Guarantee"),
identical in all material respects to the Offered Securities and the Subsidiary
Guarantees and registered under the Securities Act to be offered in exchange for
the Offered Securities (such offer to exchange being referred to as the
"Exchange Offer") and the Subsidiary Guarantees thereof and (ii) a shelf
registration statement pursuant to Rule 415 under the Securities Act (the "Shelf
Registration Statement" and, together with the Exchange Offer Registration
Statement, the "Registration Statements") relating to the resale by certain
holders of the Offered Securities and to use its best efforts to cause such
Registration Statements to be declared and remain effective and usable for the
periods specified in the Registration Rights Agreement and to consummate the
Exchange Offer. The Offered Securities, the Exchange Securities, the Subsidiary
Guarantees and the Exchange Security Guarantees are referred to collectively as
the "Securities."

         The Company hereby agrees with the several Purchasers as follows:

         2. Representations and Warranties of the Company. The Company
represents and warrants to, and agrees with, the several Purchasers that:

                 (a) A preliminary offering circular and an offering circular
         relating to the Offered Securities to be offered by the Purchasers have
         been prepared by the Company. Such preliminary offering circular (the
         "Preliminary Offering Circular") and offering circular (the "Offering
         Circular"), as supplemented as of the date of this Agreement, are
         collectively referred to as the "Offering Document." On the date of
         this Agreement, the Offering Document does not include any untrue
         statement of a material fact or omit to state any material fact
         necessary in order to make the statements therein, in the light of the
         circumstances under which they were made, not misleading. The preceding
         sentence does not apply to statements in or omissions from the Offering
         Document based upon written information furnished to the Company by any
         Purchaser through Credit Suisse First Boston Corporation ("CSFBC")
         specifically for use therein, it being understood and agreed that the
         only such information is that described as such in Section 7(b) hereof.
         Except as disclosed in the Offering Document, on the date of this
         Agreement, the "Compensation of Directors," "Security Ownership of
         Certain Beneficial Owners and Management," "Management" and "Certain
         Transactions" sections from the proxy statement of the Company filed on
         Form DEF 14A on January 23, 2002, the "Legal Matters and Contingencies"
         section from the quarterly report of the Company filed on Form 10-Q on
         August 14, 2002, and the "Description of Capital Stock" section from
         the prospectus of the Company filed on Amendment 1 to Form S-3 on
         September 7, 2001, filed with the Securities and Exchange Commission
         (the "Commission") and all subsequent reports (collectively, the
         "Exchange Act Reports") which have been filed by the Company with the
         Commission or sent to stockholders pursuant to the Securities Exchange
         Act of 1934 (the "Exchange Act") do not include any untrue statement of
         a material fact or omit to state any material fact necessary to make
         the statements therein, in the light of the circumstances under which
         they were made, not misleading. Such documents, when they were filed
         with the Commission, conformed in all material respects to the
         requirements of the Exchange Act and the rules and regulations of the
         Commission thereunder.

                 (b) The Company has been duly incorporated and is an existing
         corporation in good standing under the laws of the State of Delaware,
         with power and authority (corporate and other) to own its properties
         and conduct its business as described in the Offering Document; and the
         Company is duly qualified to do business as a foreign corporation in
         good standing in all other jurisdictions in which its ownership or
         lease of property or the conduct of its business requires such
         qualification; except to the extent that the failure to be so qualified
         or in good standing would not have a material adverse effect on the
         condition (financial or other), business, properties or result of
         operations of the Company and its subsidiaries, taken as a whole (a
         "Material Adverse Effect").

                 (c) The entities listed on Schedule C hereto are the only
         subsidiaries, direct or indirect, of the Company. Each subsidiary of
         the Company has been duly incorporated and is an existing corporation
         in good standing under the laws of the jurisdiction of its
         incorporation, with power and authority (corporate and other) to own
         its properties and conduct its business as described in the

                                       2

<PAGE>

         Offering Document; and each subsidiary of the Company is duly
         qualified to do business as a foreign corporation in good standing in
         all other jurisdictions in which its ownership or lease of property or
         the conduct of its business requires such qualification except to the
         extent that the failure to be so qualified or in good standing would
         not have a Material Adverse Effect; all of the issued and outstanding
         capital stock of each subsidiary of the Company has been duly
         authorized and validly issued and is fully paid and nonassessable; and
         the capital stock of each subsidiary owned by the Company, directly or
         through subsidiaries, is owned free from liens, encumbrances and
         defects, except for any lien or encumbrance on such capital stock to
         secure the Company's obligations under the Credit Agreement (as
         defined in the Offering Circular in the "Description of Notes"
         section).

                 (d) The Indenture has been duly authorized by the Company and
         each Guarantor, and the Subsidiary Guarantees have each been duly
         authorized by the Company and each Guarantor, all of which are listed
         on Schedule D hereto; the Offered Securities have been duly authorized;
         and when the Offered Securities are delivered and paid for pursuant to
         this Agreement on each Closing Date (as defined below) and duly
         authenticated by the Trustee in accordance with the terms of the
         Indenture, the Indenture will have been duly executed and delivered by
         the Company and each Guarantor, such Offered Securities will have been
         duly executed, authenticated, issued and delivered by the Company and
         will conform in all material respects to the description thereof
         contained in the Offering Document and the Indenture, when executed and
         delivered by the Trustee, and such Offered Securities will constitute
         valid and legally binding obligations of the Company, enforceable in
         accordance with their terms, subject to bankruptcy, insolvency,
         fraudulent transfer, reorganization, moratorium and similar laws of
         general applicability relating to or affecting creditors' rights and to
         general equity principles.

                 (e) On the Closing Date, the Indenture will conform in all
         material respects to the requirements of the Trust Indenture Act of
         1939, as amended (the "TIA" or "Trust Indenture Act"), and the rules
         and regulations of the Commission applicable to an indenture which is
         qualified thereunder.

                 (f) Except as disclosed in the Offering Document, or as
         contemplated by this Agreement, there are no contracts, agreements or
         understandings between the Company and any person that would give rise
         to a valid claim against the Company or any Purchaser for a brokerage
         commission, finder's fee or other like payment in connection with the
         offer and sale of the Offered Securities.

                 (g) This Agreement has been duly authorized, executed and
         delivered by the Company, has been duly authorized by each of the
         Guarantors and, on the Closing Date, will have been duly executed and
         delivered by each of the Guarantors.

                 (h) On the Closing Date, the Exchange Securities will have been
         duly authorized by the Company; and when the Exchange Securities are
         issued, executed and authenticated in accordance with the terms of the
         Exchange Offer and the Indenture, the Exchange Securities will be
         entitled to the benefits of the Indenture and will be the valid and
         legally binding obligations of the Company, enforceable in accordance
         with their terms, subject to bankruptcy, insolvency, fraudulent
         transfer, reorganization, moratorium and similar laws of general
         applicability relating to or affecting creditors' rights and to general
         equity principles.

                 (i) The Subsidiary Guarantee to be endorsed on the Offered
         Securities, and the Exchange Security Guarantee to be endorsed on the
         Exchange Securities, by each Guarantor have been duly authorized by
         such Guarantor; and, when issued in accordance with the terms of the
         Indenture, will have been duly executed and delivered by each such
         Guarantor and will conform to the description thereof contained in the
         Offering Document. When the Securities have been issued, executed and
         authenticated in accordance with the terms of the Indenture, the
         Subsidiary Guarantee and the Exchange Security Guarantee of each
         Guarantor endorsed thereon will constitute valid and legally binding
         obligations of such Guarantor, enforceable in accordance with its
         terms, subject to

                                        3

<PAGE>

         bankruptcy, insolvency, fraudulent transfer, reorganization,
         moratorium and similar laws of general applicability relating to or
         affecting creditors' rights and to general equity principles.

                 (j) The Registration Rights Agreement has been duly authorized
         by the Company and each of the Guarantors and, on the Closing Date,
         will have been duly executed and delivered by the Company and each of
         the Guarantors. When the Registration Rights Agreement has been duly
         executed and delivered, the Registration Rights Agreement will be a
         valid and binding agreement of the Company and each of the Guarantors,
         enforceable against the Company and each Guarantor in accordance with
         its terms, subject to bankruptcy, insolvency, fraudulent transfer,
         reorganization, moratorium and similar laws of general applicability
         relating to or affecting creditors' rights and to general equity
         principles. On the Closing Date, the Registration Rights Agreement will
         conform in all material respects as to legal matters to the description
         thereof in the Offering Circular.

                 (k) Neither the Company nor any of its subsidiaries is (i) in
         violation of its respective charter or by-laws or (ii) in default in
         the performance of any obligation, agreement, covenant or condition
         contained in any indenture, loan agreement, mortgage, lease or other
         agreement or instrument that is material to the Company and its
         subsidiaries, taken as a whole, to which the Company or any of its
         subsidiaries is a party or by which the Company or any of its
         subsidiaries or their respective property is bound, except as would
         not, individually or in the aggregate, have a Material Adverse Effect.

                 (l) No consent, approval, authorization, or order of, or filing
         with, any governmental agency or body or any court is required for the
         consummation of the transactions contemplated by this Agreement and the
         Registration Rights Agreement in connection with the issuance and sale
         of the Offered Securities by the Company except as described in or
         contemplated by the Offering Document, and except for the order of the
         Commission declaring the Exchange Offer Registration Statement or the
         Shelf Registration Statement (each as defined in the Registration
         Rights Agreement) effective.

                 (m) The execution, delivery and performance by the Company and
         the Guarantors of the Indenture, the Subsidiary Guarantees, the
         Exchange Security Guarantees, this Agreement and the Registration
         Rights Agreement, as applicable, and the issuance and sale of the
         Offered Securities and compliance by the Company with the terms and
         provisions thereof will not result in a breach or violation of any of
         the terms and provisions of, or constitute a default under, any
         statute, rule, regulation or order of any governmental agency or body
         or any court, domestic or foreign, having jurisdiction over the Company
         or any subsidiary of the Company or any of their properties, or any
         agreement or instrument to which the Company or any such subsidiary is
         a party or by which the Company or any such subsidiary is bound or to
         which any of the properties of the Company or any such subsidiary is
         subject, or the charter or by-laws of the Company or any such
         subsidiary, and the Company has full power and authority to authorize,
         issue and sell the Offered Securities as contemplated by this
         Agreement.

                 (n) Except as disclosed in the Offering Document, and for liens
         and encumbrances under the Credit Agreement, the Company and its
         subsidiaries have good and marketable title to all real properties and
         all other properties and assets owned by them, in each case free from
         liens, encumbrances and defects that would materially affect the value
         thereof or materially interfere with the use made or to be made thereof
         by them; and except as disclosed in the Offering Document, the Company
         and its subsidiaries hold any leased real or personal property under
         valid and enforceable leases with no exceptions that would materially
         interfere with the use made or to be made thereof by them.

                 (o) The Company and its subsidiaries possess adequate
         certificates, authorities or permits issued by appropriate governmental
         agencies or bodies necessary to conduct the business now operated by
         them and have not received any notice of proceedings relating to the
         revocation or

                                       4

<PAGE>

         modification of any such certificate, authority or permit that, is
         reasonably likely to be determined adversely to the Company or any of
         its subsidiaries, and if so adversely determined, would individually
         or in the aggregate have a Material Adverse Effect.

                 (p) No labor dispute with the employees of the Company or any
         subsidiary exists or, to the knowledge of the Company, is imminent that
         might have a Material Adverse Effect.

                 (q) The Company and its subsidiaries own, possess or can
         acquire on reasonable terms, adequate trademarks, trade names and other
         rights to inventions, know-how, patents, copyrights, confidential
         information and other intellectual property (collectively,
         "intellectual property rights") necessary to conduct the business now
         operated by them, or presently employed by them, and have not received
         any notice of infringement of or conflict with asserted rights of
         others with respect to any intellectual property rights that, is
         reasonably likely to be determined adversely to the Company or any of
         its subsidiaries, and if so adversely determined, would individually or
         in the aggregate have a Material Adverse Effect.

                 (r) Except as disclosed in the Offering Document, neither the
         Company nor any of its subsidiaries is in violation of any statute,
         rule, regulation, decision or order of any governmental agency or body
         or any court, domestic or foreign, relating to the use, disposal or
         release of hazardous or toxic substances or relating to the protection
         or restoration of the environment or human exposure to hazardous or
         toxic substances (collectively, "environmental laws"), owns or operates
         any real property which, to its knowledge, is contaminated with any
         substance that is subject to any environmental laws, is liable for any
         off-site disposal or contamination pursuant to any environmental laws,
         or is subject to any claim relating to any environmental laws, which
         violation, contamination, liability or claim would individually or in
         the aggregate have a Material Adverse Effect; and the Company is not
         aware of any pending investigation which might lead to such a claim.

                 (s) Except as disclosed in the Offering Document, there are no
         pending actions, suits or proceedings against or affecting the Company,
         any of its subsidiaries or any of their respective properties that, is
         reasonably likely to be determined adversely to the Company or any of
         its subsidiaries, and if so adversely determined, would individually or
         in the aggregate have a Material Adverse Effect, or would materially
         and adversely affect the ability of the Company to perform its
         obligations under the Indenture, this Agreement and the Registration
         Rights Agreement, or which are otherwise material in the context of the
         sale of the Offered Securities; and, to the Company's knowledge, no
         such actions, suits or proceedings are threatened.

                 (t) The financial statements included or incorporated by
         reference in the Offering Document present fairly, in all material
         respects, the financial position of the Company and its consolidated
         subsidiaries and Bergen Brunswig Corporation ("Bergen") and its
         consolidated subsidiaries as of the dates shown, and their respective
         results of operations and cash flows for the periods shown, and, except
         as otherwise disclosed in the Offering Document, such financial
         statements have been prepared in conformity with the generally accepted
         accounting principles in the United States applied on a consistent
         basis and the assumptions used in preparing the pro forma financial
         statements included or incorporated by reference in the Offering
         Document provide a reasonable basis for presenting the significant
         effects directly attributable to the transactions or events described
         therein, the related pro forma adjustments give appropriate effect to
         those assumptions, and the pro forma columns therein reflect the proper
         application of those adjustments to the corresponding historical
         financial statement amounts.

                 (u) Except as disclosed in the Offering Document, since the
         date of the latest audited financial statements included or
         incorporated by reference in the Offering Document there has been no
         material adverse change, nor any development or event involving a
         prospective material adverse change, in the condition (financial or
         other), business, properties or results of operations of the Company
         and its subsidiaries taken as a whole, and, except as disclosed in or
         contemplated by the

                                       5

<PAGE>

         Offering Document, there has been no dividend or distribution of any
         kind declared, paid or made by the Company on any class of its capital
         stock.

                  (v)  The Company is not an open-end investment company, unit
         investment trust or face-amount certificate company that is or is
         required to be registered under Section 8 of the United States
         Investment Company Act of 1940 (the "Investment Company Act"); and the
         Company is not and, after giving effect to the offering and sale of the
         Offered Securities and the application of the proceeds thereof as
         described in the Offering Document, will not be an "investment company"
         as defined in the Investment Company Act.

                  (w)  No securities of the same class (within the meaning of
         Rule 144A(d)(3) under the Securities Act) as the Offered Securities are
         listed on any national securities exchange registered under Section 6
         of the Exchange Act or quoted in a U.S. automated inter-dealer
         quotation system.

                  (x)  Except as disclosed in the Offering Document,
         contemplated by this Agreement or pursuant to the Company's 8 1/6%
         Senior Notes due 2008 or AmeriSource's 5% Convertible Subordinated
         Notes due 2007, there are no contracts, agreements or understandings
         between the Company or any Guarantor and any person granting such
         person the right to require the Company or such Guarantor to file a
         registration statement under the Securities Act with respect to any
         securities of the Company or such Guarantor that requires the Company
         or such Guarantor to include such securities with the Securities and
         Subsidiary Guarantees registered pursuant to any Registration
         Statement.

                  (y)  Neither the Company nor any of its subsidiaries nor any
         agent thereof acting on the behalf of them has taken, and none of them
         will take, any action that might cause this Agreement or the issuance
         or sale of the Offered Securities to violate Regulation T, Regulation U
         or Regulation X of the Board of Governors of the Federal Reserve
         System.

                  (z)  No "nationally recognized statistical rating
         organization" as such term is defined for purposes of Rule 436(g)(2)
         under the Securities Act (i) has imposed (or has informed the Company
         or any Guarantor that it is considering imposing) any condition
         (financial or otherwise) on the Company's or any Guarantor's retaining
         any rating assigned to the Company or any Guarantor, any securities of
         the Company or any Guarantor or (ii) has indicated to the Company or
         any Guarantor that it is considering (a) the downgrading, suspension,
         or withdrawal of, or any review for a possible change that does not
         indicate the direction of the possible change in, any rating so
         assigned or (b) any change in the outlook for any rating of the
         Company, any Guarantor or any securities of the Company or any
         Guarantor.

                  (aa) No form of general solicitation or general advertising
         (as defined in Regulation D under the Securities Act) was used by the
         Company, the Guarantors or any of their respective representatives
         (other than the Purchasers, as to whom the Company and the Guarantors
         make no representation) in connection with the offer and sale of the
         Offered Securities contemplated hereby, including, but not limited to,
         articles, notices or other communications published in any newspaper,
         magazine, or similar medium or broadcast over television or radio, or
         any seminar or meeting whose attendees have been invited by any general
         solicitation or general advertising. No securities of the same class as
         the Offered Securities have been issued and sold by the Company within
         the six-month period immediately prior to the date hereof.

                  (bb) None of the Company, the Guarantors nor any of their
         respective affiliates or any person acting on its or their behalf
         (other than the Purchasers, as to whom the Company and the Guarantors
         make no representation) has engaged or will engage in any directed
         selling efforts within the meaning of Regulation S under the Securities
         Act ("Regulation S") with respect to the Offered Securities or the
         Subsidiary Guarantees.

                                       6

<PAGE>

                  (cc) Assuming the accuracy of the Purchaser's representations
         set forth in Section 4 hereof, the offer and sale by the Company and
         the Guarantors of the Offered Securities and the Subsidiary Guarantees,
         respectively, in the manner contemplated by this Agreement, to the
         Purchasers and the Exempt Resales will be exempt from the registration
         requirements of the Securities Act by reason of Section 4(2) thereof
         and Regulation S thereunder; and it is not necessary to qualify an
         indenture in respect of the Offered Securities under the United States
         Trust Indenture Act of 1939, as amended (the "Trust Indenture Act").

                  (dd) None of the Company, the Guarantors nor any of their
         respective affiliates or any person acting on its or their behalf
         (other than the Purchasers, as to whom the Company and the Guarantors
         make no representation) has offered or sold, or will offer or sell, the
         Offered Securities in reliance on Regulation S other than in offshore
         transactions.

                  (ee) The sale of the Offered Securities pursuant to Regulation
         S is not part of a plan or scheme by the Company, the Guarantors or any
         of their respective affiliates or any person acting on its or their
         behalf (other than the Purchasers, as to whom the Company and the
         Guarantors make no representation) to evade the registration provisions
         of the Securities Act.

                  (ff) Neither the Company, nor any of its affiliates (as
         defined in Rule 501(b) of Regulation D), nor any person acting on its
         or their behalf (other than the Purchasers, as to whom the Company and
         the Guarantors make no representation) (i) has, within the six-month
         period prior to the date hereof, offered or sold in the United States
         or to any U.S. person (as such terms are defined in Regulation S under
         the Securities Act) the Offered Securities, or any security of the same
         class or series as the Offered Securities or (ii) has offered or will
         offer or sell the Offered Securities (A) in the United States by means
         of any form of general solicitation or general advertising within the
         meaning of Rule 502(c) under the Securities Act or (B) with respect to
         any such securities sold in reliance on Rule 903 of Regulation S
         ("Regulation S") under the Securities Act, by means of any directed
         selling efforts within the meaning of Rule 902(c) of Regulation S. The
         Company, its affiliates and any person acting on its or their behalf
         have complied and will comply with the offering restrictions
         requirement of Regulation S, provided, however, that no representation
         is made with respect to compliance by the Purchasers with the offering
         restrictions requirement of Regulation S. The Company has not entered
         and will not enter into any contractual arrangement with respect to the
         distribution of the Offered Securities except for this Agreement.

                  (gg) The proceeds to the Company from the offering of the
         Offered Securities will not be used to purchase or carry any security
         except as set forth in the Offering Document.

                  (hh) The Company is subject to Section 13 or 15(d) of the
         Exchange Act.

         3. Purchase, Sale and Delivery of Offered Securities. On the basis of
the representations, warranties and agreements herein contained, but subject to
the terms and conditions herein set forth, the Company agrees to sell to the
Purchasers, and the Purchasers agree, severally and not jointly, to purchase
from the Company, at a purchase price of 98.375% of the principal amount thereof
plus accrued interest from November 18, 2002 to the Closing Date (as hereinafter
defined), the respective principal amounts of Offered Securities set forth
opposite the names of the several Purchasers in Schedule A hereto.

         The Company will deliver against payment of the purchase price the
Offered Securities to be purchased by each Purchaser hereunder and to be offered
and sold by each Purchaser in reliance on Rule 144A under the Securities Act
(the "144A Securities") in the form of one or more permanent global securities
in registered form without interest coupons (the "Restricted Global Securities")
deposited with the Trustee as custodian for The Depository Trust Company ("DTC")
and registered in the name of Cede & Co., as nominee for DTC. The Company will
deliver against payment of the purchase price the Offered Securities to be
offered and sold by the Purchasers in reliance on Regulation S (the "Regulation
S Securities") in the form of one or more permanent global Offered Securities in
registered form without interest coupons (the

                                       7

<PAGE>

"Regulation S Global Securities") which will be deposited with the Trustee as
custodian for DTC for the respective accounts of the DTC participants for Morgan
Guaranty Trust Company of New York, Brussels office, as operator of the
Euroclear System ("Euroclear"), and Clearstream Banking societe anonyme
("Clearstream, Luxembourg") and registered in the name of Cede & Co., as nominee
for DTC. The Regulation S Global Securities and the Restricted Global Securities
shall be assigned separate CUSIP numbers. The Restricted Global Securities shall
include the legend regarding restrictions on transfer set forth under "Transfer
Restrictions" in the Offering Document. Until the termination of the restricted
period (as defined in Regulation S) with respect to the offering of the Offered
Securities, interests in the Regulation S Global Securities may only be held by
the DTC participants for Euroclear and Clearstream, Luxembourg. Interests in any
permanent global Securities will be held only in book-entry form through
Euroclear, Clearstream, Luxembourg or DTC, as the case may be, except in the
limited circumstances described in the Offering Document.

         Payment for the Regulation S Securities and the 144A Securities shall
be made by the Purchasers in Federal (same day) funds by official check or
checks or wire transfer to an account at a bank acceptable to CSFBC drawn to the
order of AmerisourceBergen Corporation at the office of Latham & Watkins, 885
Third Avenue, New York, NY 10022 at 10:00 A.M., (New York time), on November 18,
2002, or at such other time not later than seven full business days thereafter
as CSFBC and the Company determine, such time being herein referred to as the
"Closing Date", against delivery to the Trustee as custodian for DTC of (i) the
Regulation S Global Securities representing all of the Regulation S Securities
for the respective accounts of the DTC participants for Euroclear and
Clearstream, Luxembourg and (ii) the Restricted Global Securities representing
all of the 144A Securities. The Regulation S Global Securities and the
Restricted Global Securities will be made available for checking at the above
office of Latham & Watkins at least 24 hours prior to the Closing Date.

         4.  Representations by Purchasers; Resale by Purchasers.

                  (a)  Each Purchaser severally represents and warrants to the
         Company that it is an "accredited investor" within the meaning of
         Regulation D under the Securities Act.

                  (b)  Each Purchaser severally acknowledges that the Offered
         Securities have not been registered under the Securities Act and may
         not be offered or sold within the United States or to, or for the
         account or benefit of, U.S. persons except in accordance with
         Regulation S or pursuant to an exemption from the registration
         requirements of the Securities Act. Each Purchaser severally represents
         and agrees that it has offered and sold the Offered Securities, and
         will offer and sell the Offered Securities (i) as part of its
         distribution at any time and (ii) otherwise until 40 days after the
         later of the commencement of the offering and the latest Closing Date,
         only in accordance with Rule 903 or Rule 144A under the Securities Act
         ("Rule 144A"). Accordingly, neither such Purchaser nor its affiliates,
         nor any persons acting on its or their behalf, have engaged or will
         engage in any directed selling efforts with respect to the Offered
         Securities, and such Purchaser, its affiliates and all persons acting
         on its or their behalf have complied and will comply with the offering
         restrictions requirement of Regulation S. Each Purchaser severally
         agrees that, at or prior to confirmation of sale of the Offered
         Securities, other than a sale pursuant to Rule 144A, such Purchaser
         will have sent to each distributor, dealer or person receiving a
         selling concession, fee or other remuneration that purchases the
         Offered Securities from it during the restricted period a confirmation
         or notice to substantially the following effect:

                  "The Securities covered hereby have not been registered under
                  the U.S. Securities Act of 1933 (the "Securities Act") and may
                  not be offered or sold within the United States or to, or for
                  the account or benefit of, U.S. persons (i) as part of their
                  distribution at any time or (ii) otherwise until 40 days after
                  the later of the date of the commencement of the offering and
                  the closing date, except in either case in accordance with
                  Regulation S (or Rule 144A if available) under the Securities
                  Act. Terms used above have the meanings given to them by
                  Regulation S."

                                       8

<PAGE>

         Terms used in this subsection (b) have the meanings given to them by
         Regulation S.

                  (c)  Each Purchaser severally acknowledges that the Offered
         Securities have not been registered under the Securities Act and may
         not be offered or sold within the United States or to, or for the
         account or benefit of, U.S. persons except in accordance with
         Regulation S or pursuant to an exemption from the registration
         requirements of the Securities Act. Each Purchaser severally represents
         and agrees that it has offered and sold the Offered Securities, and
         will offer and sell the Offered Securities only in accordance with Rule
         903 or Rule 144A under the Securities Act ("Rule 144A"). Accordingly,
         neither such Purchaser nor its affiliates, nor any persons acting on
         its or their behalf, have engaged or will engage in any directed
         selling efforts with respect to the Offered Securities, and such
         Purchaser, its affiliates and all persons acting on its or their behalf
         have complied and will comply with the offering restrictions
         requirement of Regulation S and Rule 144A.

                  (d)  Each Purchaser severally agrees that it and each of its
         affiliates has not entered and will not enter into any contractual
         arrangement with respect to the distribution of the Offered Securities
         except for any such arrangements with the other Purchasers or
         affiliates of the other Purchasers or with the prior written consent of
         the Company.

                  (e)  Each Purchaser severally agrees that it and each of its
         affiliates will not offer or sell the Offered Securities in the United
         States by means of any form of general solicitation or general
         advertising within the meaning of Rule 502(c) under the Securities Act,
         including, but not limited to (i) any advertisement, article, notice or
         other communication published in any newspaper, magazine or similar
         media or broadcast over television or radio, or (ii) any seminar or
         meeting whose attendees have been invited by any general solicitation
         or general advertising. Each Purchaser severally agrees, with respect
         to resales made in reliance on Rule 144A of any of the Offered
         Securities, to deliver either with the confirmation of such resale or
         otherwise prior to settlement of such resale a notice to the effect
         that the resale of such Offered Securities has been made in reliance
         upon the exemption from the registration requirements of the Securities
         Act provided by Rule 144A.

                  (f)  Each of the Purchasers severally represents and agrees
         that (i) it has not authorized the Offered Securities to be offered to
         the public in the United Kingdom, within the meaning of the Public
         Offers of Securities Regulation 1995, as amended; (ii) it has only
         issued and passed on and will only issue and pass on in the United
         Kingdom the Offering Document or any other document issued in
         connection with the sale of the Offered Securities, to a person who is
         of a kind described in Article 19 of the Financial Services and Markets
         Act 2000 (Financial Promotion) Order 2001 or is a person to whom the
         document may otherwise lawfully be issued or passed on; (iii) to the
         extent it has directed the Offering Document to persons in the United
         Kingdom, it has only directed the Offering Document at persons having
         professional experience in matters relating to investments and it will
         only make the offering described in the Offering Document available to
         such persons and only such persons will be permitted to participate in
         the offering; and (iv) it has complied and will comply with all
         applicable provisions of the Financial Services and Markets Act 2002,
         as amended, with respect to anything done by it in relation to the
         Offered Securities in, from or otherwise involving the United Kingdom.

         5.  Certain Agreements of the Company.  The Company agrees with the
         several Purchasers that:

                  (a)  The Company will advise CSFBC promptly of any proposal to
         amend or supplement the Offering Document and will not effect such
         amendment or supplementation without CSFBC's consent, which consent
         shall not be unreasonably withheld. If, at any time prior to the
         completion of the resale of the Offered Securities by the Purchasers,
         any event occurs as a result of which the Offering Document as then
         amended or supplemented would include an untrue statement of a material
         fact or omit to state any material fact necessary in order to make the
         statements therein, in the light of the circumstances under which they
         were made, not misleading, the Company promptly

                                       9

<PAGE>

         will notify CSFBC of such event and promptly will prepare, at its own
         expense, an amendment or supplement which will correct such statement
         or omission. Neither CSFBC's consent to, nor the Purchasers' delivery
         to offerees or investors of, any such amendment or supplement shall
         constitute a waiver of any of the conditions set forth in Section 6.

                  (b)  The Company will furnish to CSFBC copies of any
         Preliminary Offering Circular, the Offering Document and all amendments
         and supplements to such documents, in each case as soon as available
         and in such quantities as CSFBC reasonably requests. At any time when
         the Company is not subject to Section 13 or 15(d) of the Exchange Act,
         the Company will promptly furnish or cause to be furnished to CSFBC
         (and, upon request, to each of the other Purchasers) and, upon request
         of holders and prospective purchasers of the Offered Securities, to
         such holders and purchasers, a reasonable number of copies of the
         information required to be delivered to holders and prospective
         purchasers of the Offered Securities pursuant to Rule 144A(d)(4) under
         the Securities Act (or any successor provision thereto) in order to
         permit compliance with Rule 144A in connection with resales by such
         holders of the Offered Securities. The Company will pay the expenses of
         printing and distributing to the Purchasers all such documents.

                  (c)  The Company will arrange for the qualification of the
         Offered Securities for sale and the determination of their eligibility
         for investment under the laws of such jurisdictions in the United
         States and Canada as CSFBC designates and will continue such
         qualifications in effect so long as required for the resale of the
         Offered Securities by the Purchasers, provided that the Company will
         not be required to qualify as a foreign corporation or to file a
         general consent to service of process in any such state.

                  (d)  To the extent that the Company's periodic reports under
         the Exchange Act are not readily available in the Commission's EDGAR
         system (or any successor thereto), or the Company no longer files
         periodic reports under Section 13 or 15(d) of the Exchange Act, during
         the period of five years hereafter, the Company will furnish to CSFBC
         and, upon request, to each of the other Purchasers, as soon as
         practicable after the end of each fiscal year, a copy of its annual
         report to shareholders for such year; and the Company will furnish to
         CSFBC and, upon request, to each of the other Purchasers (i) as soon as
         available, a copy of each report and any definitive proxy statement of
         the Company filed with the Commission under the Exchange Act or mailed
         to shareholders, and (ii) from time to time, such other information
         concerning the Company as CSFBC may reasonably request.

                  (e)  During the period of two years after the Closing Date or,
         if earlier until such time as the Offered Securities are no longer
         restricted securities (as defined in Rule 144 under the Securities
         Act), the Company will, upon request, furnish to CSFBC, each of the
         other Purchasers and any holder of Offered Securities a copy of the
         restrictions on transfer applicable to the Offered Securities.

                  (f)  During the period of two years after the Closing Date or,
         if earlier until such time as the Offered Securities are no longer
         restricted securities (as defined in Rule 144 under the Securities
         Act), the Company will not, and will not permit any of its affiliates
         (as defined in Rule 144 under the Securities Act) to, resell any of the
         Offered Securities that have been reacquired by any of them.

                  (g)  During the period of two years after the Closing Date or,
         if earlier until such time as the Offered Securities are no longer
         restricted securities (as defined in Rule 144 under the Securities
         Act), the Company will not be or become, an open-end investment
         company, unit investment trust or face-amount certificate company that
         is, or is required to be, registered under Section 8 of the Investment
         Company Act.

                  (h)  The Company will pay all expenses incidental to the
         performance of its obligations under this Agreement, the Indenture and
         the Registration Rights Agreement, including (i) the fees and expenses
         of the Trustee and its counsel; (ii) all expenses in connection with
         the execution, issuance,

                                       10

<PAGE>

         authentication, packaging and initial delivery of the Offered
         Securities and, as applicable, the Exchange Securities (as defined in
         the Registration Rights Agreement), the preparation and printing by the
         Company's advisors and printers of this Agreement, the Registration
         Rights Agreement, the Offered Securities, the Indenture, the Offering
         Document and amendments and supplements thereto, and any other document
         relating to the issuance, offer, sale and delivery of the Offered
         Securities and as applicable, the Exchange Securities; (iii) the cost
         of listing the Offered Securities and qualifying the Offered Securities
         for trading in The Portal(SM) Market ("PORTAL") and any expenses
         incidental thereto; (iv) the cost of any advertising approved in
         writing by the Company in connection with the issuance of the Offered
         Securities; (v) any reasonable expenses (including fees and
         disbursements of counsel) incurred in connection with qualification of
         the Offered Securities or the Exchange Securities for sale under the
         laws of such jurisdictions in the United States and Canada as CSFBC
         designates and the printing of memoranda relating thereto; (vi) for any
         fees charged by investment rating agencies for the rating of the
         Securities or the Exchange Securities; and (vii) for expenses incurred
         in distributing the Preliminary Offering Circulars and the Offering
         Document (including any amendments and supplements thereto) to the
         Purchasers. The Company will also pay or reimburse the Purchasers (to
         the extent incurred by them) for all travel expenses of the Purchasers
         and the Company's officers and employees and any other reasonable
         expenses of the Purchasers and the Company in connection with attending
         or hosting meetings between the Company and with prospective purchasers
         of the Offered Securities from the Purchasers.

                  (i) In connection with the offering, until CSFBC shall have
         notified the Company and the other Purchasers of the completion of the
         resale of the Offered Securities (which it agrees to do promptly after
         such completion), neither the Company nor any of its affiliates has or
         will, either alone or with one or more other persons, bid for or
         purchase for any account in which it or any of its affiliates has a
         beneficial interest any Offered Securities or attempt to induce any
         person to purchase any Offered Securities; and neither it nor any of
         its affiliates will make bids or purchases for the purpose of creating
         actual, or apparent, active trading in, or of raising the price of, the
         Offered Securities.

                  (j) Other than notes evidencing indebtedness under the Credit
         Agreement or any of the Company's or its subsidiaries' securitization
         facilities, for a period of 180 days after the date of the initial
         offering of the Offered Securities by the Purchasers, the Company will
         not offer, sell, contract to sell, pledge or otherwise dispose of,
         directly or indirectly, any United States dollar-denominated debt
         securities issued or guaranteed by the Company and having a maturity of
         more than one year from the date of issue except issuances of Exchange
         Securities pursuant to the Registration Rights Agreement. The Company
         will not at any time offer, sell, contract to sell, pledge or otherwise
         dispose of, directly or indirectly, any securities under circumstances
         where such offer, sale, pledge, contract or disposition would cause the
         exemption afforded by Section 4(2) of the Securities Act or the safe
         harbor of Regulation S thereunder to cease to be applicable to the
         offer and sale of the Offered Securities.

         6. Conditions of the Obligations of the Purchasers. For the purposes of
         this section, all references to "subsidiaries" shall be deemed to
         include all entities that are subsidiaries of the Company. The
         obligations of the several Purchasers to purchase and pay for the
         Offered Securities will be subject to the accuracy of the
         representations and warranties on the part of the Company herein, to
         the accuracy of the statements of officers of the Company made pursuant
         to the provisions hereof, to the performance by the Company of its
         obligations hereunder and to the following additional conditions
         precedent:

                  (a) The Purchasers shall have received letters, dated the date
         of this Agreement, from each of Deloitte & Touche LLP and Ernst & Young
         LLP in agreed form confirming that they are independent public
         accountants within the meaning of the Securities Act and the applicable
         published rules and regulations thereunder ("Rules and Regulations") in
         form and substance previously agreed to by the Purchasers and their
         counsel.

                                       11

<PAGE>

                  (b) Subsequent to the execution and delivery of this
         Agreement, there shall not have occurred (i) any change, or any
         development or event involving a prospective change, in the condition
         (financial or other), business, properties or results of operations of
         the Company and its subsidiaries taken as one enterprise which, in the
         judgment of a majority in interest of the Purchasers including CSFBC,
         is material and adverse and makes it impractical or inadvisable to
         proceed with completion of the offering or the sale of and payment for
         the Offered Securities; (ii) any downgrading in the rating of any debt
         securities of the Company by any "nationally recognized statistical
         rating organization" (as defined for purposes of Rule 436(g) under the
         Securities Act), or any public announcement that any such organization
         has under surveillance or review its rating of any debt securities of
         the Company (other than an announcement with positive implications of a
         possible upgrading, and no implication of a possible downgrading, of
         such rating) or any announcement that the Company has been placed on
         negative outlook; (iii) any change in U.S. or international financial,
         political or economic conditions or currency exchange rates or exchange
         controls as would, in the interest of a majority in interest of the
         Purchasers including CSFB, be likely to prejudice materially the
         success of the proposed issue, sale or distribution of the Offered
         Securities, whether in the primary market or in respect of dealings in
         the secondary market; (iv) any material suspension or material
         limitation of trading in securities generally on the New York Stock
         Exchange, or any setting of minimum prices for trading on such
         exchange, or any suspension of trading of any securities of the Company
         on any exchange or in the over-the-counter market; (v) any banking
         moratorium declared by U.S. Federal or New York authorities; (vi) any
         major disruption of settlements of securities or clearance services in
         the United States; or (vii) any attack on, outbreak or escalation of
         hostilities or act of terrorism involving the United States, any
         declaration of war by Congress or any other national or international
         calamity or emergency if, in the judgment of a majority in interest of
         the Purchasers including CSFBC, the effect of any such attack,
         outbreak, escalation, act, declaration, calamity or emergency makes it
         impractical or inadvisable to proceed with completion of the offering
         or sale of and payment for the Offered Securities.

                  (c) The Purchasers shall have received an opinion, dated such
         Closing Date, of Dechert, counsel for the Company, that:

                          (i)  The Company has been duly incorporated and is
                  validly existing as a corporation in good standing under the
                  laws of the State of Delaware, with corporate power and
                  authority to own its properties and conduct its business as
                  described in the Offering Document; and, based solely on such
                  counsel's review of certificates of qualification to do
                  business as a foreign corporation, the Company is duly
                  qualified to do business as a foreign corporation in good
                  standing in all other jurisdictions set forth in an exhibit to
                  the opinion (which exhibit shall identify, based solely on a
                  certificate of an officer of the Company, each jurisdiction in
                  which the Company owns or leases material properties or
                  conducts material business) except to the extent that the
                  failure to be so qualified or be in good standing would not
                  have a Material Adverse Effect.

                          (ii) Each Guarantor incorporated or formed in the
                  State of California, the State of Connecticut, the State of
                  Delaware, the State of New Jersey, the State of New York or
                  the Commonwealth of Pennsylvania (the "Relevant Guarantors")
                  has been, to the extent a corporation, duly incorporated, and,
                  to the extent a limited liability company or limited
                  partnership, duly formed and is validly existing and in good
                  standing under the laws of the jurisdiction of its
                  incorporation or formation and has the corporate, limited
                  liability company or limited partnership power and authority
                  to own its property and to conduct its business as described
                  in the Offering Document; and each Relevant Guarantor, based
                  solely on such counsel's review of certificates of
                  qualification to do business as a foreign corporation, is duly
                  qualified to transact business and is in good standing in each
                  jurisdiction set forth in an exhibit to the opinion (which
                  exhibit shall identify, based solely on a certificate of an
                  officer of the Company, each jurisdiction in which the Company
                  or

                                       12

<PAGE>

         any Relevant Guarantor owns or leases material properties or conducts
         material business) except to the extent that the failure to be so
         qualified or be in good standing would not have a Material Adverse
         Effect.

              (iii)  The Indenture has been duly authorized, executed and
         delivered by the Company and the Relevant Guarantors; the Offered
         Securities have been duly authorized, executed and delivered by the
         Company; the Subsidiary Guarantees have been duly authorized, executed
         and delivered by the Relevant Guarantors; and the Indenture, the
         Offered Securities and such Subsidiary Guarantees, when duly
         authenticated by the Trustee in accordance with the terms of the
         Indenture and delivered and paid for in accordance with the terms of
         this Agreement, constitute valid and legally binding obligations of the
         Company and the Relevant Guarantors, respectively, enforceable in
         accordance with their terms, subject to bankruptcy, insolvency,
         fraudulent transfer, reorganization, moratorium and similar laws of
         general applicability relating to or affecting creditors' rights and to
         general equity principles.

              (iv)   Assuming that the Indenture and the Subsidiary Guarantees
         have been duly authorized, executed and delivered by each Guarantor
         other than the Relevant Guarantors, the Indenture and the Offered
         Securities, when duly authenticated by the Trustee in accordance with
         the terms of the Indenture and delivered and paid for in accordance
         with the terms of this Agreement, constitute valid and legally binding
         obligations of each Guarantor other than the Relevant Guarantors,
         enforceable in accordance with their terms, subject to bankruptcy,
         insolvency, fraudulent transfer, reorganization, moratorium and similar
         laws of general applicability relating to or affecting creditors'
         rights and to general equity principles.

              (v)    The Company is not and, after giving effect to the offering
         and sale of the Offered Securities and the application of the proceeds
         thereof as described in the Offering Circular, will not be an
         "investment company" as defined in the Investment Company Act.

              (vi)   No consent, approval, authorization or order of, or filing
         with, any governmental agency or body or any court is required for the
         offer and sale of the Securities or the transactions contemplated by
         the Registration Rights Agreement (subject to the assumptions set forth
         in paragraph (xi) as it relates to the Securities Act and the Trust
         Indenture Act), except such as may be required under state securities
         or blue sky laws or regulations and, with respect to the Exchange Offer
         Registration Statement, the Registration Rights Agreement and the
         transactions contemplated thereunder, as may be required under the
         Securities Act or the Exchange Act or the rules and regulations of the
         Commission promulgated thereunder or the bylaws of the National
         Association of Securities Dealers, Inc.

              (vii)  Except as set forth in, or incorporated by reference in,
         the Offering Document, there are, to such counsel's knowledge, no
         pending or threatened actions, suits or proceedings against or
         affecting the Company, any of its subsidiaries or any of their
         respective properties that, is reasonably likely to be determined
         adversely to the Company or any of its subsidiaries, and if so
         adversely determined would individually or in the aggregate have a
         Material Adverse Effect, or would materially and adversely affect the
         ability of the Company to perform its obligations under the Indenture,
         this Agreement or the Registration Rights Agreement.

              (viii) The execution, delivery and performance by the Company of
         the Indenture, this Agreement and the Registration Rights Agreement, as
         applicable, and the issuance and sale by the Company of the Offered
         Securities and compliance with the terms and provisions thereof, will
         not result in a breach or violation of any of the terms and provisions

                                       13

<PAGE>

         of, or constitute a default under, (i) any statute, rule, regulation
         applicable to the Company or, to such counsel's knowledge, order of
         any governmental agency or body or any court having jurisdiction over
         the Company or any subsidiary of the Company or any of their
         properties (other than a breach or violation that is not likely to
         cause a Material Adverse Effect), (ii) any agreement or instrument,
         set forth in an exhibit to the opinion (which exhibit shall identify,
         based solely on a certificate of an officer of the Company, all
         material agreements or instruments of the Company) (other than a
         breach or violation that is not likely to cause a Material Adverse
         Effect) or (iii) the charter or by-laws of the Company or any such
         subsidiary, and the Company has full power and authority to authorize,
         issue and sell the Offered Securities as contemplated by this
         Agreement.

              (ix)   Such counsel has no reason to believe that the descriptions
         in the Offering Circular under the caption "Description of the Notes,"
         insofar as they purport to constitute a summary of the terms of the
         Offered Securities, and under the captions "Certain United States
         Federal Income Tax Consequences" and "Transfer Restrictions," insofar
         as they purport to describe the provisions of the law and documents
         referred to therein, do not summarize in all material respects the
         matters referred to therein.

              (x)    This Agreement has been duly authorized, executed and
         delivered by the Company and the Guarantors.

              (xi)   Assuming (A) the accuracy of the representations and
         warranties of the Company set forth in Items (w), (y), (aa), (bb),
         (cc), (dd), (ee) and (ff) of Section 2 of this Agreement, (B) the due
         performance by the Company of the agreements set forth in Section 5 of
         this Agreement, (C) the accuracy of the representations and warranties
         made by the Purchasers of the agreement set forth in Section 4 of this
         Agreement, (D) compliance by the Purchasers with the offering and
         transfer procedures and restrictions described elsewhere in this
         Agreement and the Offering Document and (E) the accuracy of the
         representations and warranties made in accordance with this Agreement
         and the Offering Document by purchasers to whom the Purchasers
         initially resell the Offered Securities, it is not necessary in
         connection with (i) the offer, sale and delivery of the Offered
         Securities by the Company to the several Purchasers pursuant to this
         Agreement or (ii) the resales of the Offered Securities by the several
         Purchasers in the manner contemplated by this Agreement, to register
         the Offered Securities under the Securities Act (it being understood
         that no opinion shall be expressed as to any resale subsequent to the
         initial resale of the Offered Securities); and it is not necessary in
         connection with the offer, sale, or delivery of the Offered Securities
         to the initial Purchasers in the manner contemplated by the Purchase
         Agreement or in connection with the Exempt Resales to qualify the
         Indenture under the Trust Indenture Act.

              (xii)  The Indenture conforms in all material respects to the
         requirements of the Trust Indenture Act of 1939, as amended (the "TIA"
         or "Trust Indenture Act"), and the rules and regulations of the
         Commission applicable to an indenture which is qualified thereunder.

              (xiii) The Exchange Securities and the Exchange Security
         Guarantees have been duly authorized by the Company and each of the
         Relevant Guarantors, as applicable.

              (xiv)  The Registration Rights Agreement has been duly authorized,
         executed and delivered by the Company and each of the Relevant
         Guarantors, and (assuming due authorization, execution and delivery by
         the parties thereto other than the Company and the Relevant Guarantors)
         is a valid and binding agreement of the Company and each of the
         Guarantors, enforceable against the Company and each Guarantor in
         accordance with its terms, subject to bankruptcy, insolvency,
         fraudulent transfer, reorganization, moratorium

                                       14

<PAGE>

         and similar laws of general applicability relating to or affecting
         creditors' rights and to general equity principles.

              (xv) To such counsel's knowledge, there are no contracts,
         agreements or understandings between the Company or any Guarantor and
         any person granting such person the right to require the Company or
         such Guarantor to file a registration statement under the Securities
         Act with respect to any securities of the Company or such Guarantor and
         to require the Company or such Guarantor to include such securities
         with the Securities and Subsidiary Guarantees registered pursuant to
         any Registration Statement.

         In rendering such opinion, such counsel may rely as to matters of fact,
to the extent they deem proper, on certificates of responsible officers of the
Company and public officials. Such opinion may be limited to the General
Corporation Law and the Limited Liability Company Act of the State of Delaware,
the New Jersey Business Corporation Act, the laws of the State of California,
the laws of the State of Connecticut, the laws of the State of New York, the
laws of the Commonwealth of Pennsylvania and the federal laws of the United
States.

         Such counsel shall also state, in a separate letter, that, in the
course of preparation by the Company of the Offering Circular, such counsel has
participated in conferences with directors, officers and other representatives
of the Company, representatives of the independent public accountants for the
Company, representatives of the Purchasers and representatives of counsel for
the Purchasers, at which conferences the contents of the Offering Circular and
related matters were discussed and, although such counsel has not independently
verified and is not passing upon and assumes no responsibility for the accuracy,
completeness or fairness of the statements contained in the Offering Circular
(except as expressly provided above), and noting that they have relied as to
materiality to a large extent upon the statements of directors, officers and
other representatives of the Company, on the basis of the information that was
developed in the course of the performance of the services referred to above,
considered in light of such counsel's understanding of the applicable law, no
facts have come to such counsel's attention which has caused such counsel to
believe that as of the date of the Offering Document and at the Closing Date,
the Offering Circular contained an untrue statement of a material fact or
omitted to state any material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading (it being understood that such counsel need express no view with
respect to the financial statements and the notes related thereto or any other
financial data, statistical data derived from financial data and accounting data
included or incorporated by reference in the Offering Circular).

         (d) The Purchasers shall have received an opinion, dated the Closing
Date, of Dechert, counsel to the Company, for each Guarantor not incorporated or
formed under the laws of California, Connecticut, Delaware, New Jersey, New York
or Pennsylvania, that:

              (i)   each of the relevant Guarantors has been duly incorporated
         and is validly existing as a corporation in good standing under the
         laws of the jurisdiction in which it is chartered or organized, with
         corporate power and authority to own its properties and conduct its
         business as described in the Offering Document;

              (ii)  each of the Subsidiary Guarantees has been duly authorized,
         executed and delivered and each of the Exchange Securities Guarantees
         has been duly authorized, in each case by each of the relevant
         Guarantors that is a party hereto or thereto; and

              (iii) the Indenture and the Registration Rights Agreement has been
         duly authorized, executed and delivered by each of the relevant
         Guarantors.

                                       15

<PAGE>

                  In rendering such opinion, such counsel may rely (A) as to
        matters involving the application of laws of any jurisdiction other than
        the jurisdiction in which the relevant Guarantors are chartered or
        organized or the United States, to the extent they deem proper and
        specified in such opinion, upon the opinion of other counsel who are
        satisfactory to counsel for the Purchasers, and (B) as to matters of
        fact, to the extent they deem proper, on certificates of responsible
        officers of the relevant Guarantors and public officials. Furthermore,
        such counsel may assume, for the purpose of rendering such opinion, that
        the laws of the jurisdiction in which the relevant Guarantors are
        chartered or organized are identical to the laws of Delaware.

                  (e) The Purchasers shall have received from Latham & Watkins,
         counsel for the Purchasers, such opinion or opinions, dated such
         Closing Date, with respect to the incorporation of the Company, the
         validity of the Offered Securities, the Offering Circular, the
         exemption from registration for the offer and sale of the Offered
         Securities by the Company to the several Purchasers and the resales by
         the several Purchasers as contemplated hereby and other related matters
         as CSFBC may require, and the Company shall have furnished to such
         counsel such documents as they reasonably request for the purpose of
         enabling them to pass upon such matters.

                  (f) The Purchasers shall have received a certificate, dated
         the Closing Date, of the President or any Vice President and a
         principal financial or accounting officer of the Company in which such
         officers, to the best of their knowledge after reasonable
         investigation, shall state that the representations and warranties of
         the Company in this Agreement are true and correct, that the Company
         has complied with all agreements and satisfied all conditions on its
         part to be performed or satisfied hereunder at or prior to the Closing
         Date, and that, subsequent to the date of the most recent financial
         statements included or incorporated by reference in the Offering
         Document there has been no material adverse change, nor any development
         or event involving a prospective material adverse change, in the
         condition (financial or other), business, properties or results of
         operations of the Company and its subsidiaries taken as a whole except
         as set forth in or contemplated by the Offering Document or as
         described in such certificate.

                  (g) The Purchasers shall have received letters, dated the
         Closing Date, from each of Deloitte & Touche LLP and Ernst & Young LLP
         which meet the requirements of subsection (a) of this Section, except
         that the specified date referred to in such subsection will be a date
         not more than five days prior to the Closing Date for the purposes of
         this subsection.

                  (h) The Purchasers shall have received a certificate, dated
         the Closing Date, of the Senior Vice President and Chief Financial
         Officer of the Company stating that:

                      (i)  as of September 30, 2002, the amount that would have
         been available to the Company for Restricted Payments pursuant to the
         second clause (3) of the first paragraph under the section "Description
         of Notes -- Certain Covenants -- Restricted Payments" in the Offering
         Document was $294.2 million; and

                      (ii) as of September 30, 2002, those subsidiaries of the
         Company designated as "Designated Non-Guarantors" in an officers'
         certificate delivered to the Purchasers and the Trustee pursuant to the
         definition of "Designated Non-Guarantors" in the Indenture,
         individually and in the aggregate, represent less than 3.0% of the
         Company's consolidated total assets, consolidated stockholders' equity,
         consolidated revenues, consolidated income from continuing operations
         before income taxes and consolidated cash flows from operating
         activities.

                  Documents described as being "in the agreed form" are
       documents which are in the forms which have been initialled for the
       purpose of identification by Latham & Watkins, copies of which are held
       by the Company and CSFBC, with such changes as CSFBC may approve.

                                       16

<PAGE>

                  The Company will furnish the Purchasers with such conformed
       copies of such opinions, certificates, letters and documents as the
       Purchasers reasonably request. CSFBC may in its sole discretion waive on
       behalf of the Purchasers compliance with any conditions to the
       obligations of the Purchasers hereunder.

         7.  Indemnification and Contribution.

                  (a) The Company and the Guarantors will, jointly and
         severally, indemnify and hold harmless each Purchaser, its partners,
         directors and officers and each person, if any, who controls such
         Purchaser within the meaning of Section 15 of the Securities Act,
         against any losses, claims, damages or liabilities, joint or several,
         to which such Purchaser may become subject, under the Securities Act or
         the Exchange Act or otherwise, insofar as such losses, claims, damages
         or liabilities (or actions in respect thereof) arise out of or are
         based upon any untrue statement or alleged untrue statement of any
         material fact contained in the Offering Document, or any amendment or
         supplement thereto, or any related Preliminary Offering Circular or the
         Exchange Act Reports, or arise out of or are based upon the omission or
         alleged omission to state therein a material fact necessary in order to
         make the statements therein, in the light of the circumstances under
         which they were made, not misleading, including any losses, claims,
         damages or liabilities arising out of or based upon the Company's
         failure to perform its obligations under Section 5(a) of this
         Agreement, and will reimburse each Purchaser for any legal or other
         expenses reasonably incurred by such Purchaser in connection with
         investigating or defending any such loss, claim, damage, liability or
         action as such expenses are incurred; provided, however, that the
         Company will not be liable in any such case to the extent that any such
         loss, claim, damage or liability (i) arises out of or is based upon an
         untrue statement or alleged untrue statement in or omission or alleged
         omission from any of such documents in reliance upon and in conformity
         with written information furnished to the Company by any Purchaser
         through CSFBC specifically for use therein, it being understood and
         agreed that the only such information consists of the information
         described as such in subsection (b) below or (ii) results from the fact
         that such Purchaser failed to deliver an Offering Circular, as then
         amended or supplemented, (so long as the Offering Circular and any
         amendment or supplement thereto was provided by the Company to the
         Purchasers in the requisite quantity and on a timely basis to permit
         proper delivery on or prior to the Closing Date) to the person
         asserting any losses, claims, damages, liabilities or judgments caused
         by any untrue statement or omission or alleged untrue statement or
         omission of a material fact contained in any Preliminary Offering
         Circular, and such untrue statement or alleged untrue statement or
         omission was cured in the Offering Circular.

                  (b) Each Purchaser will severally and not jointly indemnify
         and hold harmless the Company, each Guarantor, their directors and
         officers and each person, if any, who controls the Company or such
         Guarantor within the meaning of Section 15 of the Securities Act,
         against any losses, claims, damages or liabilities to which the Company
         or such Guarantor may become subject, under the Securities Act or the
         Exchange Act or otherwise, insofar as such losses, claims, damages or
         liabilities (or actions in respect thereof) arise out of or are based
         upon any untrue statement or alleged untrue statement of any material
         fact contained in the Offering Document, or any amendment or supplement
         thereto, or any related Preliminary Offering Circular, or arise out of
         or are based upon the omission or the alleged omission to state therein
         a material fact necessary in order to make the statements therein, in
         the light of the circumstances under which they were made, not
         misleading, in each case to the extent, but only to the extent, that
         such untrue statement or alleged untrue statement or omission or
         alleged omission was made in reliance upon and in conformity with
         written information furnished to the Company by such Purchaser through
         CSFBC specifically for use therein, and will reimburse any legal or
         other expenses reasonably incurred by the Company in connection with
         investigating or defending any such loss, claim, damage, liability or
         action as such expenses are incurred, it being understood and agreed
         that the only such information furnished by any Purchaser consists of
         (i) the following information in the Offering Document furnished on
         behalf of each Purchaser: under the caption "Plan of Distribution"
         paragraphs three, ten and twelve and the third sentence of paragraph
         nine; provided, however, that the Purchasers shall not be liable for
         any

                                       17

<PAGE>

         losses, claims, damages or liabilities arising out of or based upon the
         Company's failure to perform its obligations under Section 5(a) of this
         Agreement.

                  (c) Promptly after receipt by an indemnified party under this
         Section of written notice of the commencement of any action, such
         indemnified party will, if a claim in respect thereof is to be made
         against the indemnifying party under subsection (a) or (b) above,
         notify the indemnifying party of the commencement thereof; but the
         omission so to notify the indemnifying party in writing will not
         relieve it from any liability which it may have to any indemnified
         party otherwise than under subsection (a) or (b) above. In case any
         such action is brought against any indemnified party and it notifies
         the indemnifying party of the commencement thereof, the indemnifying
         party will be entitled to participate therein and, to the extent that
         it may elect by written notice, jointly with any other indemnifying
         party similarly notified, to assume the defense thereof, with counsel
         reasonably satisfactory to such indemnified party. After notice from
         the indemnifying party to such indemnified party of its election so to
         assume the defense thereof, the indemnifying party will not be liable
         to such indemnified party under this Section for any legal or other
         expenses subsequently incurred by such indemnified party in connection
         with the defense thereof other than reasonable costs of investigation
         prior to assumption of defenses. No indemnifying party shall, without
         the prior written consent of the indemnified party, effect any
         settlement of any pending or threatened action in respect of which any
         indemnified party is or could have been a party and indemnity could
         have been sought hereunder by such indemnified party unless such
         settlement includes (i) an unconditional release of such indemnified
         party from all liability on any claims that are the subject matter of
         such action and (ii) does not include a statement as to or an admission
         of fault, culpability or failure to act by or on behalf of any
         indemnified party.

                  (d) If the indemnification provided for in this Section is
         unavailable or insufficient to hold harmless an indemnified party under
         subsection (a) or (b) above, then each indemnifying party shall
         contribute to the amount paid or payable by such indemnified party as a
         result of the losses, claims, damages or liabilities referred to in
         subsection (a) or (b) above (i) in such proportion as is appropriate to
         reflect the relative benefits received by the Company on the one hand
         and the Purchasers on the other from the offering of the Offered
         Securities or (ii) if the allocation provided by clause (i) above is
         not permitted by applicable law, in such proportion as is appropriate
         to reflect not only the relative benefits referred to in clause (i)
         above but also the relative fault of the Company on the one hand and
         the Purchasers on the other in connection with the statements or
         omissions which resulted in such losses, claims, damages or liabilities
         as well as any other relevant equitable considerations. The relative
         benefits received by the Company on the one hand and the Purchasers on
         the other shall be deemed to be in the same proportion as the total net
         proceeds from the offering (before deducting expenses) received by the
         Company bear to the total discounts and commissions received by the
         Purchasers from the Company under this Agreement. The relative fault
         shall be determined by reference to, among other things, whether the
         untrue or alleged untrue statement of a material fact or the omission
         or alleged omission to state a material fact relates to information
         supplied by the Company or the Purchasers and the parties' relative
         intent, knowledge, access to information and opportunity to correct or
         prevent such untrue statement or omission. The amount paid by an
         indemnified party as a result of the losses, claims, damages or
         liabilities referred to in the first sentence of this subsection (d)
         shall be deemed to include any legal or other expenses reasonably
         incurred by such indemnified party in connection with investigating or
         defending any action or claim which is the subject of this subsection
         (d). Notwithstanding the provisions of this subsection (d), no
         Purchaser shall be required to contribute any amount in excess of the
         amount by which the total discounts, fees and commissions received by
         such Purchaser exceeds the amount of any damages which such Purchaser
         has otherwise been required to pay by reason of such untrue or alleged
         untrue statement or omission or alleged omission. The Purchasers'
         obligations in this subsection (d) to contribute are several in
         proportion to their respective purchase obligations and not joint.

                  (e) The obligations of the Company and the Guarantors under
         this Section shall be in addition to any liability which the Company
         and the Guarantors may otherwise have and shall

                                       18

<PAGE>

         extend, upon the same terms and conditions, to each person, if any, who
         controls any Purchaser within the meaning of the Securities Act or the
         Exchange Act; and the obligations of the Purchasers under this Section
         shall be in addition to any liability which the respective Purchasers
         may otherwise have and shall extend, upon the same terms and
         conditions, to each person, if any, who controls the Company or the
         Guarantors within the meaning of the Securities Act or the Exchange
         Act.

         8.  Default of Purchasers. If any Purchaser or Purchasers default in
their obligations to purchase Offered Securities hereunder and the aggregate
principal amount of Offered Securities that such defaulting Purchaser or
Purchasers agreed but failed to purchase does not exceed 10% of the total
principal amount of Offered Securities, CSFBC may make arrangements satisfactory
to the Company for the purchase of such Offered Securities by other persons,
including any of the Purchasers, but if no such arrangements are made by such
Closing Date, the non-defaulting Purchasers shall be obligated severally, in
proportion to their respective commitments hereunder, to purchase the Offered
Securities that such defaulting Purchasers agreed but failed to purchase on such
Closing Date. If any Purchaser or Purchasers so default and the aggregate
principal amount of Offered Securities with respect to which such default or
defaults occur exceeds 10% of the total principal amount of Offered Securities
and arrangements satisfactory to CSFBC and the Company for the purchase of such
Offered Securities by other persons are not made within 36 hours after such
default, this Agreement will terminate without liability on the part of any
non-defaulting Purchaser or the Company, except as provided in Section 9. As
used in this Agreement, the term "Purchaser" includes any person substituted for
a Purchaser under this Section. Nothing herein will relieve a defaulting
Purchaser from liability for its default.

         9.  Survival of Certain Representations and Obligations. The respective
indemnities, agreements, representations, warranties and other statements of the
Company or its officers and of the several Purchasers set forth in or made
pursuant to this Agreement will remain in full force and effect, regardless of
any investigation, or statement as to the results thereof, made by or on behalf
of any Purchaser, the Company or any of their respective representatives,
officers or directors or any controlling person, and will survive delivery of
and payment for the Offered Securities. If this Agreement is terminated pursuant
to Section 8 or if for any reason the purchase of the Offered Securities by the
Purchasers is not consummated, the Company shall remain responsible for the
expenses to be paid or reimbursed by it pursuant to Section 5 and the respective
obligations of the Company and the Purchasers pursuant to Section 7 shall remain
in effect. If the purchase of the Offered Securities by the Purchasers is not
consummated for any reason other than solely because of the termination of this
Agreement pursuant to Section 8 or the occurrence of any event specified in
clause (iii), (iv), (v), (vi) or (vii) of Section 6(b), the Company will
reimburse the Purchasers for all out-of-pocket expenses (including fees and
disbursements of counsel) reasonably incurred by them in connection with the
offering of the Offered Securities.

         10. Notices. All communications hereunder will be in writing and, if
sent to the Purchasers will be mailed, delivered or telegraphed and confirmed to
the Purchasers, c/o Credit Suisse First Boston Corporation, Eleven Madison
Avenue, New York, N.Y. 10010-3629, Attention: Investment Banking Department -
Transactions Advisory Group, if sent to the Company or the Guarantors, will be
mailed, delivered or telegraphed and confirmed to it at AmerisourceBergen
Corporation, 1300 Morris Drive, Suite 100, Chesterbrook, PA 19087-5594,
Attention: General Counsel; provided, however, that any notice to a Purchaser
pursuant to Section 7 will be mailed, delivered or telegraphed and confirmed to
such Purchaser.

         11. Successors. This Agreement will inure to the benefit of and be
binding upon the parties hereto and their respective successors and the
controlling persons referred to in Section 7, and no other person will have any
right or obligation hereunder, except that holders of Offered Securities shall
be entitled to enforce the agreements for their benefit contained in the second
and third sentences of Section 5(b) hereof against the Company as if such
holders were parties thereto.

         12. Representation of Purchasers.  CSFBC, Banc of America Securities
LLC and J.P. Morgan Securities Inc. will act for the several Purchasers in
connection with this purchase, and any action under this

                                       19

<PAGE>

Agreement taken by CSFBC, Banc of America Securities LLC and J.P. Morgan
Securities Inc. jointly or by CSFBC will be binding upon all the Purchasers.

         13.  Counterparts.  This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, but all such
counterparts shall together constitute one and the same Agreement.

         14.  Applicable Law. This Agreement shall be governed by, and construed
in accordance with, the laws of the State of New York without regard to
principles of conflicts of laws.

         The Company and the Guarantors hereby submit to the non-exclusive
jurisdiction of the Federal and state courts in the Borough of Manhattan in The
City of New York in any suit or proceeding arising out of or relating to this
Agreement or the transactions contemplated hereby.

         If the foregoing is in accordance with the Purchasers' understanding of
our agreement, kindly sign and return to us one of the counterparts hereof,
whereupon it will become a binding agreement among the Company, the Guarantors
and the several Purchasers in accordance with its terms.

                            [SIGNATURE PAGE ATTACHED]

                                       20

<PAGE>

                                          Very truly yours,

                                          AmerisourceBergen Corporation

                                          By /s/ J. F. Quinn
                                             -------------------------------
                                             Name: J.F. Quinn
                                             Title: Vice President and Corporate
                                                     Treasurer

AmerisourceBergen Purchase Agreement

<PAGE>

                            Very truly yours,

                            AmerisourceBergen Drug Corporation
                            AmerisourceBergen Services Corporation
                            AmeriSource Health Services Corporation
                            ASD Specialty Healthcare, Inc.
                            AutoMed Technologies, Inc.
                            Brownstone Pharmacy, Inc.
                            Capstone Pharmacy of Delaware, Inc.
                            Compuscript, Inc.
                            Computran Systems, Inc.
                            Dunnington Rx Services of Rhode Island, Inc.
                            Family Center Pharmacy, Inc.
                            Goot Nursing Home Pharmacy, Inc.
                            Health Services Capital Corporation
                            Insta-Care Pharmacy Services Corporation
                            ION, LLC
                            James Brudnick Company, Inc.
                            Medical Initiatives, Inc.
                            MediDyne Corp.
                            Pharmacy Corporation of America, Inc.
                            Pharmacy Corporation of America-Massachusetts, Inc.
                            PharMerica Drug Systems, Inc.
                            PharMerica, Inc.
                            Premier Pharmacy, Inc.
                            Southwest Pharmacies, Inc.
                            The Lash Group, Inc.
                            Tmesys(TM), Inc.

                            By /s/ William D. Sprague
                               ------------------------
                            Name: William D. Sprague
                            Title: Vice President

AmerisourceBergen Purchase Agreement

<PAGE>

                                             Very truly yours,

                                             AmeriSource Heritage Corporation

                                             By /s/ Daniel T. Hirst
                                                --------------------------------
                                                Name: Daniel T. Hirst
                                                Title: Vice President

AmerisourceBergen Purchase Agreement

<PAGE>

The foregoing Purchase Agreement
  is hereby confirmed and accepted
  as of the date first above written.

Credit Suisse First Boston Corporation
Banc of America Securities LLC
J.P. Morgan Securities Inc.

  Acting on behalf of themselves
  and as the Representatives of
  the several Purchasers

By Credit Suisse First Boston Corporation

         By ___________________
            Name:
            Title:

AmerisourceBergen Purchase Agreement

<PAGE>

                                   SCHEDULE A

                                                         Principal Amount of
                                                         Offered Securities
                                                         ------------------
                  Manager
                  -------
Credit Suisse First Boston Corporation .....................      $90,000,000
Banc of America Securities LLC .............................       75,000,000
J.P. Morgan Securities Inc. ................................       75,000,000
Fleet Securities, Inc ......................................       15,000,000
Mizuho International plc ...................................       15,000,000
Scotia Capital (USA) Inc ...................................       15,000,000
Wachovia Securities, Inc ...................................       15,000,000
                                                                 ------------
                          Total ............................     $300,000,000
                                                                 ============

                                       25

<PAGE>

                                   SCHEDULE B

                        [List of Documents Delivered with
                               Offering Circular]

None

                                       26

<PAGE>

                                   SCHEDULE C

                             [List of Subsidiaries]

                               Guarantor Entities

AmerisourceBergen Drug Corporation
AmerisourceBergen Services Corporation
AmeriSource Health Services Corporation
AmeriSource Heritage Corporation
ASD Specialty Healthcare, Inc.
AutoMed Technologies, Inc.
Brownstone Pharmacy, Inc.
Capstone Pharmacy of Delaware, Inc.
Compuscript, Inc.
Computran Systems, Inc.
Dunnington Rx Services of Rhode Island, Inc.
Family Center Pharmacy, Inc.
Goot Nursing Home Pharmacy, Inc.
Health Services Capital Corporation
Insta-Care Pharmacy Services Corporation
ION, LLC
James Brudnick Company, Inc.
Medical Initiatives, Inc.
MediDyne Corp.
Pharmacy Corporation of America, Inc.
Pharmacy Corporation of America-Massachusetts, Inc.
PharMerica Drug Systems, Inc.
PharMerica, Inc.
Premier Pharmacy, Inc.
Southwest Pharmacies, Inc.
The Lash Group, Inc.
Tmesys(TM), Inc.

                            Receivables Subsidiaries

AmeriSource Receivables Financial Corporation
Blue Hill II, Inc.

                             Non-Guarantor Entities

Alliance Health Services, Inc.
Alliance Home Health Care, Inc.
AmeriSource Sales Corporation
ASD Hemophilia Management, LLC
ASD Hemophilia Program, L.P.
BBC Laboratories
BBC Operating Sub, Inc.
BBC Packing Corporation
BBC Special Packaging, Inc.
BBC Transportation Company
Bergen Brunswig Realty Services, Inc.
Beverly Acquisition Corporation

                                       27

<PAGE>

Blue Hill, Inc.
Capstone Med, Inc.
Century Advertising, Inc.
Choice Medical, Inc.
Committed Provider Services, LLC
Corrections Pharmacies Licensing Company, LLC
Corrections Pharmacies of California, LP
Corrections Pharmacies of Hawaii, LP
Corrections Pharmacies, LLC
DD Wholesale, Inc.
Drug Service, Inc.
Dunnington Drug, Inc.
Dunnington Rx Services of Massachusetts, Inc.
Express Pharmacy Services, Inc.
General Drug Company
Goot Westbridge Pharmacy, Inc.
Goot's Goodies, Inc.
Goot's Pharmacy & Orthopedic Supply, Inc.
Green Barn, Inc.
Healthcare Prescription Services, Inc.
Home Medical Equipment Health Company
Insta-Care Holdings, Inc.
Integrated Commercialization Solutions, Inc.
Inteplex, Inc.
Interfill, LLC
J.M. Blanco, Inc.
K/S Instrument Corp.
LAD Drug Corporation
Lexicon Pharmacy Services, LLC
Los Angeles Drug Corporation
M.D.P. Properties, Inc.
Medical Health Industries, Inc.
Omni Med B, Inc.
Pharmacy Dynamics Group, Inc.
Pharmacy Healthcare Solutions, Ltd.
Pryzm, Inc.
Reimbursement Education Network, LLC
RightPak, Inc.
Rombro's Drug Center, Inc.
Southwestern Drug Corporation
Stadt Solutions, LLC
Telepharmacy Solutions, Inc.
The Allen Company
Value Apothecaries, Inc.

                                       28

<PAGE>

                                   SCHEDULE D

                              [List of Guarantors]

AmerisourceBergen Drug Corporation
AmerisourceBergen Services Corporation
AmeriSource Health Services Corporation
AmeriSource Heritage Corporation
ASD Specialty Healthcare, Inc.
AutoMed Technologies, Inc.
Brownstone Pharmacy, Inc.
Capstone Pharmacy of Delaware, Inc.
Compuscript, Inc.
Computran Systems, Inc.
Dunnington Rx Services of Rhode Island, Inc.
Family Center Pharmacy, Inc.
Goot Nursing Home Pharmacy, Inc.
Health Services Capital Corporation
Insta-Care Pharmacy Services Corporation
ION, LLC
James Brudnick Company, Inc.
Medical Initiatives, Inc.
MediDyne Corp.
Pharmacy Corporation of America, Inc.
Pharmacy Corporation of America-Massachusetts, Inc.
PharMerica Drug Systems, Inc.
PharMerica, Inc.
Premier Pharmacy, Inc.
Southwest Pharmacies, Inc.
The Lash Group, Inc.
Tmesys(TM), Inc.

                                       29

<PAGE>

                                    Exhibit I

                     [Form of Registration Rights Agreement]

                                       30<PAGE>

                                                                    EXHIBIT 4.36

                                  $300,000,000

                          AmerisourceBergen Corporation

                          7 1/4% Senior Notes due 2012

                          REGISTRATION RIGHTS AGREEMENT

                                                               November 18, 2002

Credit Suisse First Boston Corporation
Banc of America Securities LLC
J.P. Morgan Securities Inc.
     as Representatives of the several Initial Purchasers
c/o  Credit Suisse First Boston Corporation
     Eleven Madison Avenue
     New York, New York 10010-3629

Dear Sirs:

       AmerisourceBergen Corporation, a Delaware corporation (the "Issuer"),
proposes to issue and sell to Credit Suisse First Boston Corporation, Banc of
America Securities LLC, J.P. Morgan Securities Inc. and the other Initial
Purchasers named in the purchase agreement described below (collectively, the
"Initial Purchasers"), upon the terms set forth in a purchase agreement of even
date herewith (the "Purchase Agreement"), $300,000,000 aggregate principal
amount of its 7 1/4% Senior Notes due 2012 (the "Initial Securities") to be
guaranteed (the "Guaranties") by the subsidiaries of the Company set forth on
Schedule I hereto, (the "Guarantors" and, collectively with the Issuer, the
"Company"). The Initial Securities will be issued pursuant to an Indenture,
dated as of November 18, 2002 (the "Indenture"), among the Issuer, the
Guarantors and J.P. Morgan Trust Company, National Association, as trustee (the
"Trustee"). As an inducement to the Initial Purchasers to enter into the
Purchase Agreement, the Company agrees with the Initial Purchasers, for the
benefit of the Initial Purchasers and the holders of the Securities (as defined
below) (collectively the "Holders"), as follows:

       1.     Registered Exchange Offer. Unless not permitted by applicable law
(after the Company has complied with the ultimate paragraph of this Section 1),
the Company shall prepare and, not later than 90 days (such 90th day being a
"Filing Deadline") after the date on which the Initial Purchasers purchase the
Initial Securities pursuant to the Purchase Agreement (the "Closing Date"), file
with the Securities and Exchange Commission (the "Commission") a registration
statement (the "Exchange Offer Registration Statement") on an appropriate form
under the Securities Act of 1933, as amended (the "Securities Act"), with
respect to a proposed offer (the "Registered Exchange Offer") to the Holders of
Transfer Restricted Securities (as defined in Section 6 hereof), who are not
prohibited by any law or policy of the Commission from participating in the
Registered Exchange Offer, to issue and deliver to such Holders, in exchange for
the Initial Securities, a like aggregate principal amount of debt securities of
the Company issued under the Indenture, identical in all material respects to
the Initial Securities

<PAGE>

(except for the transfer restrictions relating to the Initial Securities and the
provisions related to the matters described in Section 6 hereof) and registered
under the Securities Act (the "Exchange Securities"). The Company shall use all
commercially reasonable efforts to (i) cause such Exchange Offer Registration
Statement to become effective under the Securities Act within 180 days after the
Closing Date (such 180th day being an "Effectiveness Deadline") and (ii) keep
the Exchange Offer Registration Statement effective for not less than 30 days
(or longer, if required by applicable law) after the date notice of the
Registered Exchange Offer is mailed to the Holders (such period being called the
"Exchange Offer Registration Period").

       If the Company commences the Registered Exchange Offer, the Company (i)
will be entitled to consummate the Registered Exchange Offer 30 days after such
commencement (provided that the Company has accepted all the Initial Securities
theretofore validly tendered in accordance with the terms of the Registered
Exchange Offer) and (ii) will be required to consummate the Registered Exchange
Offer no later than 40 days after the date on which the Exchange Offer
Registration Statement is declared effective (such 40th day being the
"Consummation Deadline").

       Following the declaration of the effectiveness of the Exchange Offer
Registration Statement, the Company shall promptly commence the Registered
Exchange Offer, it being the objective of such Registered Exchange Offer to
enable each Holder of Transfer Restricted Securities electing to exchange the
Initial Securities for Exchange Securities (assuming that such Holder is not an
affiliate of the Company within the meaning of the Securities Act, acquires the
Exchange Securities in the ordinary course of such Holder's business and has no
arrangements with any person to participate in the distribution of the Exchange
Securities and is not prohibited by any law or policy of the Commission from
participating in the Registered Exchange Offer) to trade such Exchange
Securities from and after their receipt without any limitations or restrictions
under the Securities Act and without material restrictions under the securities
laws of the several states of the United States.

       The Company acknowledges that, pursuant to current interpretations by the
Commission's staff of Section 5 of the Securities Act, in the absence of an
applicable exemption therefrom, (i) each Holder which is a broker-dealer
electing to exchange Initial Securities, acquired for its own account as a
result of market making activities or other trading activities, for Exchange
Securities (an "Exchanging Dealer"), is required in connection with any resale
of such Exchange Securities to deliver a prospectus containing the information
set forth in (a) Annex A hereto on the cover, (b) Annex B hereto in the
"Exchange Offer Procedures" section and the "Purpose of the Exchange Offer"
section, and (c) Annex C hereto in the "Plan of Distribution" section of such
prospectus in connection with a sale of any such Exchange Securities received by
such Exchanging Dealer pursuant to the Registered Exchange Offer and (ii) an
Initial Purchaser that elects to sell Securities (as defined below) acquired in
exchange for Initial Securities constituting any portion of an unsold allotment,
is required to deliver a prospectus containing the information required by Items
507 or 508 of Regulation S-K under the Securities Act, as applicable, in
connection with such sale.

       The Company shall use its best efforts to keep the Exchange Offer
Registration Statement effective and to amend and supplement the prospectus
contained therein, in order to permit such prospectus to be lawfully delivered
by all persons subject to the prospectus delivery requirements

                         Registration Rights Agreement

<PAGE>

of the Securities Act for such period of time as such persons must comply with
such requirements in order to resell the Exchange Securities; provided, however,
that (i) in the case where such prospectus and any amendment or supplement
thereto must be delivered by an Exchanging Dealer or an Initial Purchaser, such
period shall be the lesser of 180 days and the date on which all Exchanging
Dealers and the Initial Purchasers have sold all Exchange Securities held by
them (unless such period is extended pursuant to Section 3(j) below) and (ii)
the Company shall make such prospectus and any amendment or supplement thereto
available to any broker-dealer for use in connection with any resale of any
Exchange Securities for a period of not less than 180 days after the
consummation of the Registered Exchange Offer.

       If, upon consummation of the Registered Exchange Offer, any Initial
Purchaser holds Initial Securities acquired by it as part of its initial
distribution, the Company, simultaneously with the delivery of the Exchange
Securities pursuant to the Registered Exchange Offer, shall issue and deliver to
such Initial Purchaser upon the written request of such Initial Purchaser, in
exchange (the "Private Exchange") for the Initial Securities held by such
Initial Purchaser, a like principal amount of debt securities of the Company
issued under the Indenture and identical in all material respects (including the
existence of restrictions on transfer under the Securities Act and the
securities laws of the several states of the United States, but excluding
provisions relating to matters described in Section 6 hereof) to the Initial
Securities (the "Private Exchange Securities"). The Initial Securities, the
Exchange Securities and the Private Exchange Securities are herein collectively
called the "Securities."

       In connection with the Registered Exchange Offer, the Company shall:

              (a)    mail to each Holder a copy of the prospectus forming part
       of the Exchange Offer Registration Statement, together with an
       appropriate letter of transmittal and related documents;

              (b)    keep the Registered Exchange Offer open for not less than
       30 days (or longer, if required by applicable law) after the date notice
       thereof is mailed to the Holders;

              (c)    utilize the services of a depositary for the Registered
       Exchange Offer with an address in the Borough of Manhattan, The City of
       New York, The State of New York, which may be the Trustee or an affiliate
       of the Trustee;

              (d)    permit Holders to withdraw tendered Initial Securities at
       any time prior to the close of business, New York time, on the last
       business day on which the Registered Exchange Offer shall remain open;
       and

              (e)    otherwise comply with all applicable laws.

       As soon as practicable after the close of the Registered Exchange Offer
or the Private Exchange, as the case may be, the Company shall:

              (x)    accept for exchange all the Initial Securities validly
       tendered and not withdrawn pursuant to the Registered Exchange Offer and
       the Private Exchange;

                         Registration Rights Agreement

<PAGE>

              (y)    deliver to the Trustee for cancellation all the Initial
       Securities so accepted for exchange; and

              (z)    cause the Trustee to authenticate and deliver promptly to
       each Holder of the Initial Securities, Exchange Securities or Private
       Exchange Securities, as the case may be, equal in principal amount to the
       Initial Securities of such Holder so accepted for exchange.

       The Indenture will provide that the Exchange Securities will not be
subject to the transfer restrictions set forth in the Indenture and that all the
Securities will vote and consent together on all matters as one class and that
none of the Securities will have the right to vote or consent as a class
separate from one another on any matter.

       Interest on each Exchange Security and Private Exchange Security issued
pursuant to the Registered Exchange Offer and in the Private Exchange will
accrue from the last interest payment date on which interest was paid on the
Initial Securities surrendered in exchange therefor or, if no interest has been
paid on the Initial Securities, from the date of original issue of the Initial
Securities.

       Each Holder participating in the Registered Exchange Offer shall be
required to represent to the Company that at the time of the consummation of the
Registered Exchange Offer (i) any Exchange Securities received by such Holder
will be acquired in the ordinary course of business, (ii) such Holder will have
no arrangements or understanding with any person to participate in the
distribution of the Securities or the Exchange Securities within the meaning of
the Securities Act, (iii) such Holder is not an "affiliate," as defined in Rule
405 of the Securities Act, of the Company or if it is an affiliate, such Holder
will comply with the registration and prospectus delivery requirements of the
Securities Act to the extent applicable, (iv) if such Holder is not a
broker-dealer, that it is not engaged in, and does not intend to engage in, the
distribution of the Exchange Securities and (v) if such Holder is a
broker-dealer, that it will receive Exchange Securities for its own account in
exchange for Initial Securities that were acquired as a result of market-making
activities or other trading activities and that it will be required to
acknowledge that it will deliver a prospectus in connection with any resale of
such Exchange Securities.

       Notwithstanding any other provisions hereof, the Company will ensure that
(i) any Exchange Offer Registration Statement and any amendment thereto and any
prospectus forming part thereof and any supplement thereto complies in all
material respects with the Securities Act and the rules and regulations
thereunder, (ii) any Exchange Offer Registration Statement and any amendment
thereto does not, when it becomes effective, contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading and (iii) any prospectus
forming part of any Exchange Offer Registration Statement, and any supplement to
such prospectus, does not include an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary in order to
make the statements therein, in the light of the circumstances under which they
were made, not misleading.

       If following the date hereof there has been announced a change in
Commission policy with respect to exchange offers that in the reasonable opinion
of counsel to the Company raises a

                          Registration Rights Agreement

<PAGE>

substantial question as to whether the Registered Exchange Offer is permitted by
applicable federal law, the Company will seek a no-action letter or other
favorable decision from the Commission allowing the Company to consummate the
Registered Exchange Offer, unless the Company makes a good faith determination
based on the advise of counsel that such a request would be denied in light of
publicly available no-action letters, in which case the Company shall proceed to
file a Shelf Registration Statement pursuant to the provisions of Section 2
hereof. In the event the Company seeks a no-action letter or other favorable
decision from the Commission pursuant to the preceding sentence, the Company
will pursue the issuance of such a decision to the Commission staff level. In
connection with the foregoing, the Company will take all such other actions as
may be requested by the Commission or otherwise required in connection with the
issuance of such decision, including without limitation (i) participating in
telephonic conferences with the Commission, (ii) delivering to the Commission
staff an analysis prepared by counsel to the Company setting forth the legal
bases, if any, upon which such counsel has concluded that the Registered
Exchange Offer should be permitted and (iii) diligently pursuing a resolution
(which need not be favorable) by the Commission staff.

       2.     Shelf Registration. If, (i) because of any change in law or in
applicable interpretations thereof by the staff of the Commission, the Company
is not permitted to effect a Registered Exchange Offer, as contemplated by
Section 1 hereof, (ii) the Registered Exchange Offer is not consummated by the
180th day after the Closing Date, (iii) any Initial Purchaser so requests with
respect to the Initial Securities (or the Private Exchange Securities) not
eligible to be exchanged for Exchange Securities in the Registered Exchange
Offer and held by it following consummation of the Registered Exchange Offer or
(iv) any Holder (other than an Exchanging Dealer) is not eligible to participate
in the Registered Exchange Offer or, in the case of any Holder (other than an
Exchanging Dealer) that participates in the Registered Exchange Offer, such
Holder does not receive freely tradeable Exchange Securities on the date of the
exchange and any such Holder so requests, the Company shall take the following
actions (the date on which any of the conditions described in the foregoing
clauses (i) through (iv) occur, including in the case of clauses (iii) or (iv)
the receipt of the required notice, being a "Trigger Date"):

              (a)    The Company shall use all commercially reasonable efforts
       to, no more than 60 days after the Trigger Date (such 60th day being a
       "Filing Deadline"), file with the Commission and thereafter use all
       commercially reasonable efforts to cause to be declared effective no
       later than 120 days after the Trigger Date (such 120th day being an
       "Effectiveness Deadline") a registration statement (the "Shelf
       Registration Statement" and, together with the Exchange Offer
       Registration Statement, a "Registration Statement") on an appropriate
       form under the Securities Act relating to the offer and sale of the
       Transfer Restricted Securities by the Holders thereof from time to time
       in accordance with the methods of distribution set forth in the Shelf
       Registration Statement and Rule 415 under the Securities Act
       (hereinafter, the "Shelf Registration"); provided, however, that no
       Holder (other than an Initial Purchaser) shall be entitled to have the
       Securities held by it covered by such Shelf Registration Statement unless
       such Holder agrees in writing to be bound by all the provisions of this
       Agreement applicable to such Holder.

              (b)    The Company shall use its best efforts to keep the Shelf
       Registration Statement continuously effective in order to permit the
       prospectus included therein to be

                         Registration Rights Agreement

<PAGE>

       lawfully delivered by the Holders of the relevant Securities, for a
       period of two years (or for such longer period if extended pursuant to
       Section 3(j) below) from the date of its effectiveness or such shorter
       period that will terminate when all the Securities covered by the Shelf
       Registration Statement (i) have been sold pursuant thereto or (ii) are no
       longer restricted securities (as defined in Rule 144 under the Securities
       Act, or any successor rule thereof). The Company shall be deemed not to
       have used its best efforts to keep the Shelf Registration Statement
       effective during the requisite period if it voluntarily takes any action
       that would result in Holders of Securities covered thereby not being able
       to offer and sell such Securities during that period, unless such action
       is required by applicable law.

              (c)    Notwithstanding any other provisions of this Agreement to
       the contrary, the Company shall cause the Shelf Registration Statement
       and the related prospectus and any amendment or supplement thereto, as of
       the effective date of the Shelf Registration Statement, amendment or
       supplement, (i) to comply in all material respects with the applicable
       requirements of the Securities Act and the rules and regulations of the
       Commission and (ii) not to contain any untrue statement of a material
       fact or omit to state a material fact required to be stated therein or
       necessary in order to make the statements therein, in light of the
       circumstances under which they were made, not misleading.

       3.     Registration Procedures. In connection with any Shelf Registration
contemplated by Section 2 hereof and, to the extent applicable, any Registered
Exchange Offer contemplated by Section 1 hereof, the following provisions shall
apply:

              (a)    The Company shall (i) furnish to each Initial Purchaser,
       prior to the filing thereof with the Commission, a copy of the
       Registration Statement and each amendment thereof and each supplement, if
       any, to the prospectus included therein and, in the event that an Initial
       Purchaser (with respect to any portion of an unsold allotment from the
       original offering) is participating in the Registered Exchange Offer or
       the Shelf Registration Statement, the Company shall use its best efforts
       to reflect in each such document, when so filed with the Commission, such
       comments as such Initial Purchaser reasonably may propose; (ii) include
       the information set forth in Annex A hereto on the cover, in Annex B
       hereto in the "Exchange Offer Procedures" section and the "Purpose of the
       Exchange Offer" section and in Annex C hereto in the "Plan of
       Distribution" section of the prospectus forming a part of the Exchange
       Offer Registration Statement and include the information set forth in
       Annex D hereto in the Letter of Transmittal delivered pursuant to the
       Registered Exchange Offer; (iii) if requested by an Initial Purchaser,
       include the information required by Items 507 or 508 of Regulation S-K
       under the Securities Act, as applicable, in the prospectus forming a part
       of the Exchange Offer Registration Statement; (iv) include within the
       prospectus contained in the Exchange Offer Registration Statement a
       section entitled "Plan of Distribution," reasonably acceptable to the
       Initial Purchasers, which shall contain a summary statement of the
       positions taken or policies made by the staff of the Commission with
       respect to the potential "underwriter" status of any broker-dealer that
       is the beneficial owner (as defined in Rule 13d-3 under the Securities
       Exchange Act of 1934, as amended (the "Exchange Act")) of Exchange
       Securities received by such broker-dealer in the Registered Exchange
       Offer (a "Participating Broker-Dealer"), whether such positions or
       policies have been

                         Registration Rights Agreement

<PAGE>

       publicly disseminated by the staff of the Commission or such positions or
       policies, in the reasonable judgment of the Initial Purchasers based upon
       advice of counsel (which may be in-house counsel), represent the
       prevailing views of the staff of the Commission; and (v) in the case of a
       Shelf Registration Statement, include the names of the Holders who
       propose to sell Securities pursuant to the Shelf Registration Statement
       as selling securityholders.

              (b)    The Company shall give written notice to the Initial
       Purchasers, the Holders of the Securities and any Participating
       Broker-Dealer from whom the Company has received prior written notice
       that it will be a Participating Broker-Dealer in the Registered Exchange
       Offer (which notice pursuant to clauses (ii)-(v) hereof shall be
       accompanied by an instruction to suspend the use of the prospectus until
       the requisite changes have been made):

                     (i)    when the Registration Statement or any amendment
              thereto has been filed with the Commission and when the
              Registration Statement or any post-effective amendment thereto has
              become effective;

                     (ii)   of any request by the Commission for amendments or
              supplements to the Registration Statement or the prospectus
              included therein or for additional information;

                     (iii)  of the issuance by the Commission of any stop order
              suspending the effectiveness of the Registration Statement or the
              initiation of any proceedings for that purpose;

                     (iv)   of the receipt by the Company or its legal counsel
              of any notification with respect to the suspension of the
              qualification of the Securities for sale in any jurisdiction or
              the initiation or threatening of any proceeding for such purpose;
              and

                     (v)    of the happening of any event that requires the
              Company to make changes in the Registration Statement or the
              prospectus in order that the Registration Statement or the
              prospectus do not contain an untrue statement of a material fact
              nor omit to state a material fact required to be stated therein or
              necessary to make the statements therein (in the case of the
              prospectus, in light of the circumstances under which they were
              made) not misleading.

              (c)    The Company shall make every reasonable effort to obtain
       the withdrawal at the earliest possible time, of any order suspending the
       effectiveness of the Registration Statement.

              (d)    The Company shall furnish to each Holder of Securities
       included within the coverage of the Shelf Registration, without charge,
       at least one copy of the Shelf Registration Statement and any
       post-effective amendment thereto, including financial statements and
       schedules, and, if the Holder so requests in writing, all exhibits
       thereto (including those, if any, incorporated by reference).

                         Registration Rights Agreement

<PAGE>

              (e)    The Company shall deliver to each Exchanging Dealer and
       each Initial Purchaser, and to any other Holder who so requests, without
       charge, at least one copy of the Exchange Offer Registration Statement
       and any post-effective amendment thereto, including financial statements
       and schedules, and, if any Initial Purchaser or any such Holder requests,
       all exhibits thereto (including those incorporated by reference).

              (f)    The Company shall, during the Shelf Registration Period,
       deliver to each Holder of Securities included within the coverage of the
       Shelf Registration, without charge, as many copies of the prospectus
       (including each preliminary prospectus) included in the Shelf
       Registration Statement and any amendment or supplement thereto as such
       person may reasonably request. The Company consents, subject to the
       provisions of this Agreement, to the use of the prospectus or any
       amendment or supplement thereto by each of the selling Holders of the
       Securities in connection with the offering and sale of the Securities
       covered by the prospectus, or any amendment or supplement thereto,
       included in the Shelf Registration Statement.

              (g)    The Company shall deliver to each Initial Purchaser, any
       Exchanging Dealer, any Participating Broker-Dealer and such other persons
       required to deliver a prospectus following the Registered Exchange Offer,
       without charge, as many copies of the final prospectus included in the
       Exchange Offer Registration Statement and any amendment or supplement
       thereto as such persons may reasonably request. The Company consents,
       subject to the provisions of this Agreement, to the use of the prospectus
       or any amendment or supplement thereto by any Initial Purchaser, if
       necessary, any Participating Broker-Dealer and such other persons
       required to deliver a prospectus following the Registered Exchange Offer
       in connection with the offering and sale of the Exchange Securities
       covered by the prospectus, or any amendment or supplement thereto,
       included in such Exchange Offer Registration Statement.

              (h)    Prior to any public offering of the Securities pursuant to
       any Registration Statement the Company shall register or qualify or
       cooperate with the Holders of the Securities included therein and their
       respective counsel in connection with the registration or qualification
       of the Securities for offer and sale under the securities or "blue sky"
       laws of such states of the United States as any Holder of the Securities
       reasonably requests in writing and do any and all other acts or things
       necessary or advisable to enable the offer and sale in such jurisdictions
       of the Securities covered by such Registration Statement; provided,
       however, that the Company shall not be required to (i) qualify generally
       to do business in any jurisdiction where it is not then so qualified or
       (ii) take any action which would subject it to general service of process
       or to taxation in any jurisdiction where it is not then so subject.

              (i)    The Company shall cooperate with the Holders of the
       Securities to facilitate the timely preparation and delivery of
       certificates representing the Securities to be sold pursuant to any
       Registration Statement free of any restrictive legends and in such
       denominations and registered in such names as the Holders may request a
       reasonable period of time prior to sales of the Securities pursuant to
       such Registration Statement.

                          Registration Rights Agreement

<PAGE>

              (j)    Upon the occurrence of any event contemplated by paragraphs
       (ii) through (v) of Section 3(b) above during the period for which the
       Company is required to maintain an effective Registration Statement, the
       Company shall promptly prepare and file a post-effective amendment to the
       Registration Statement or a supplement to the related prospectus and any
       other required document so that, as thereafter delivered to Holders of
       the Securities or purchasers of Securities, the prospectus will not
       contain an untrue statement of a material fact or omit to state any
       material fact required to be stated therein or necessary to make the
       statements therein, in light of the circumstances under which they were
       made, not misleading. If the Company notifies the Initial Purchasers, the
       Holders of the Securities and any known Participating Broker-Dealer in
       accordance with paragraphs (ii) through (v) of Section 3(b) above to
       suspend the use of the prospectus until the requisite changes to the
       prospectus have been made, then the Initial Purchasers, the Holders of
       the Securities and any such Participating Broker-Dealers shall suspend
       use of such prospectus, and the period of effectiveness of the Shelf
       Registration Statement provided for in Section 2(b) above and the
       Exchange Offer Registration Statement provided for in Section 1 above
       shall each be extended by the number of days from and including the date
       of the giving of such notice to and including the date when the Initial
       Purchasers, the Holders of the Securities and any known Participating
       Broker-Dealer shall have received such amended or supplemented prospectus
       pursuant to this Section 3(j).

              (k)    Not later than the effective date of the applicable
       Registration Statement, the Company will provide a CUSIP number for the
       Initial Securities, the Exchange Securities or the Private Exchange
       Securities, as the case may be, and provide the applicable trustee with
       printed certificates for the Initial Securities, the Exchange Securities
       or the Private Exchange Securities, as the case may be, in a form
       eligible for deposit with The Depository Trust Company.

              (l)    The Company will comply with all rules and regulations of
       the Commission to the extent and so long as they are applicable to the
       Registered Exchange Offer or the Shelf Registration and will make
       generally available to its security holders (or otherwise provide in
       accordance with Section 11(a) of the Securities Act) an earnings
       statement satisfying the provisions of Section 11(a) of the Securities
       Act, no later than 45 days after the end of a 12-month period (or 90
       days, if such period is a fiscal year) beginning with the first month of
       the Company's first fiscal quarter commencing after the effective date of
       the Registration Statement, which statement shall cover such 12-month
       period.

              (m)    The Company shall cause the Indenture to be qualified under
       the Trust Indenture Act of 1939, as amended, in a timely manner and
       containing such changes, if any, as shall be necessary for such
       qualification. In the event that such qualification would require the
       appointment of a new trustee under the Indenture, the Company shall
       appoint a new trustee thereunder pursuant to the applicable provisions of
       the Indenture.

              (n)    The Company may require each Holder of Securities to be
       sold pursuant to the Shelf Registration Statement to furnish to the
       Company such information regarding the Holder and the distribution of the
       Securities as the Company may from time to time

                         Registration Rights Agreement

<PAGE>

       reasonably require for inclusion in the Shelf Registration Statement, and
       the Company may exclude from such registration the Securities of any
       Holder that unreasonably fails to furnish such information within a
       reasonable time after receiving such request.

              (o)    The Company shall enter into such customary agreements
       (including, if requested, an underwriting agreement in customary form)
       and take all such other action, if any, as any Holder of the Securities
       shall reasonably request in order to facilitate the disposition of the
       Securities pursuant to any Shelf Registration.

              (p)    In the case of any Shelf Registration, the Company shall
       (i) make reasonably available for inspection by the Holders of the
       Securities, any underwriter participating in any disposition pursuant to
       the Shelf Registration Statement and any attorney, accountant or other
       agent retained by the Holders of the Securities or any such underwriter
       all relevant financial and other records, pertinent corporate documents
       and properties of the Company and (ii) cause the Company's officers,
       directors, employees, accountants and auditors to supply all relevant
       information reasonably requested by the Holders of the Securities or any
       such underwriter, attorney, accountant or agent in connection with the
       Shelf Registration Statement, in each case, as shall be reasonably
       necessary to enable such persons, to conduct a reasonable investigation
       within the meaning of Section 11 of the Securities Act; provided,
       however, that the foregoing inspection and information gathering shall be
       coordinated on behalf of the Initial Purchasers by you and on behalf of
       the other parties, by one counsel designated by and on behalf of such
       other parties as described in Section 4 hereof; and provided, further,
       that as to any information that is designated in writing by the Company,
       in good faith, as confidential at the time of delivery, such information
       shall be kept confidential by the Holder or by any such underwriter,
       attorney, accountant or other agent.

              (q)    In the case of any Shelf Registration, the Company, if
       requested by any Holder of Securities covered thereby, shall cause (i)
       its counsel to deliver an opinion and updates thereof relating to the
       Securities in customary form addressed to such Holders and the managing
       underwriters, if any, thereof and dated, in the case of the initial
       opinion, the effective date of such Shelf Registration Statement (it
       being agreed that the matters to be covered by such opinion shall
       include, without limitation, the due incorporation and good standing of
       the Company and its material subsidiaries; the qualification of the
       Company and its material subsidiaries to transact business as foreign
       corporations; the due authorization, execution and delivery of the
       relevant agreement of the type referred to in Section 3(o) hereof; the
       due authorization, execution, authentication and issuance, and the
       validity and enforceability, of the applicable Securities; the absence of
       material legal or governmental proceedings involving the Company and its
       subsidiaries; the absence of governmental approvals required to be
       obtained in connection with the Shelf Registration Statement, the
       offering and sale of the applicable Securities, or any agreement of the
       type referred to in Section 3(o) hereof; the compliance as to form of
       such Shelf Registration Statement and any documents incorporated by
       reference therein and of the Indenture with the requirements of the
       Securities Act and the Trust Indenture Act, respectively; and, as of the
       date of the opinion and as of the effective date of the Shelf
       Registration Statement or most recent post-effective amendment thereto,
       as the case may be, the absence from such Shelf

                          Registration Rights Agreement

<PAGE>

       Registration Statement and the prospectus included therein, as then
       amended or supplemented, and from any documents incorporated by reference
       therein of an untrue statement of a material fact or the omission to
       state therein a material fact required to be stated therein or necessary
       to make the statements therein not misleading (in the case of any such
       documents, in the light of the circumstances existing at the time that
       such documents were filed with the Commission under the Exchange Act);
       (ii) its officers to execute and deliver all customary documents and
       certificates and updates thereof reasonably requested by any underwriters
       of the applicable Securities and (iii) its independent public accountants
       and the independent public accountants with respect to any other entity
       for which financial information is provided in the Shelf Registration
       Statement to provide to the selling Holders of the applicable Securities
       and any underwriter therefor a comfort letter in customary form and
       covering matters of the type customarily covered in comfort letters in
       connection with primary underwritten offerings, subject to receipt of
       appropriate documentation as contemplated, and only if permitted, by
       Statement of Auditing Standards No. 72.

              (r)    In the case of the Registered Exchange Offer, if requested
       by any Initial Purchaser or any known Participating Broker-Dealer, the
       Company shall cause (i) its counsel to deliver to such Initial Purchaser
       or such Participating Broker-Dealer a signed opinion in the form set
       forth in Section 6(c) of the Purchase Agreement with such changes as are
       customary in connection with the preparation of a Registration Statement
       and (ii) its independent public accountants and the independent public
       accountants with respect to any other entity for which financial
       information is provided in the Registration Statement to deliver to such
       Initial Purchaser or such Participating Broker-Dealer a comfort letter,
       in customary form, meeting the requirements as to the substance thereof
       as set forth in Section 6(a) of the Purchase Agreement, with appropriate
       date changes.

              (s)    If a Registered Exchange Offer or a Private Exchange is to
       be consummated, upon delivery of the Initial Securities by Holders to the
       Company (or to such other Person as directed by the Company) in exchange
       for the Exchange Securities or the Private Exchange Securities, as the
       case may be, the Company shall mark, or caused to be marked, on the
       Initial Securities so exchanged that such Initial Securities are being
       canceled in exchange for the Exchange Securities or the Private Exchange
       Securities, as the case may be; in no event shall the Initial Securities
       be marked as paid or otherwise satisfied.

              (t)    The Company will use its best efforts to (a) if the Initial
       Securities have been rated prior to the initial sale of such Initial
       Securities, confirm such ratings will apply to the Securities covered by
       a Registration Statement, or (b) if the Initial Securities were not
       previously rated, cause the Securities covered by a Registration
       Statement to be rated with the appropriate rating agencies, if so
       requested by Holders of a majority in aggregate principal amount of
       Securities covered by such Registration Statement, or by the managing
       underwriters, if any.

              (u)    In the event that any broker-dealer registered under the
       Exchange Act shall underwrite any Securities or participate as a member
       of an underwriting syndicate or selling group or "assist in the
       distribution" (within the meaning of the Conduct Rules

                          Registration Rights Agreement

<PAGE>

       (the "Rules") of the National Association of Securities Dealers, Inc.
       ("NASD")) thereof, whether as a Holder of such Securities or as an
       underwriter, a placement or sales agent or a broker or dealer in respect
       thereof, or otherwise, the Company will assist such broker-dealer in
       complying with the requirements of such Rules, including, without
       limitation, by (i) if such Rules, including Rule 2720, shall so require,
       engaging a "qualified independent underwriter" (as defined in Rule 2720)
       to participate in the preparation of the Registration Statement relating
       to such Securities, to exercise usual standards of due diligence in
       respect thereto and, if any portion of the offering contemplated by such
       Registration Statement is an underwritten offering or is made through a
       placement or sales agent, to recommend the yield of such Securities, (ii)
       indemnifying any such qualified independent underwriter to the extent of
       the indemnification of underwriters provided in Section 5 hereof and
       (iii) providing such information to such broker-dealer as may be required
       in order for such broker-dealer to comply with the requirements of the
       Rules.

              (v)    The Company shall use its best efforts to take all other
       steps necessary to effect the registration of the Securities covered by a
       Registration Statement contemplated hereby.

       4.     Registration Expenses.(a) (a) All expenses incident to the
Company's performance of and compliance with this Agreement will be borne by the
Company, regardless of whether a Registration Statement is ever filed or becomes
effective, including without limitation;

                     (i)    all registration and filing fees and expenses;

                     (ii)   all fees and expenses of compliance with federal
              securities and state "blue sky" or securities laws;

                     (iii)  all expenses of printing (including printing
              certificates for the Securities to be issued in the Registered
              Exchange Offer and the Private Exchange and printing of
              Prospectuses), messenger and delivery services and telephone;

                     (iv)   all fees and disbursements of counsel for the
              Company;

                     (v)    all application and filing fees in connection with
              listing the Exchange Securities on a national securities exchange
              or automated quotation system pursuant to the requirements hereof;
              and

                     (vi)   all fees and disbursements of independent certified
              public accountants of the Company (including the expenses of any
              special audit and comfort letters required by or incident to such
              performance).

The Company will bear its internal expenses (including, without limitation, all
salaries and expenses of its officers and employees performing legal or
accounting duties), the expenses of any annual audit and the fees and expenses
of any person, including special experts, retained by the Company.

                          Registration Rights Agreement

<PAGE>

              (b)    In connection with any Registration Statement required by
this Agreement, the Company will reimburse the Initial Purchasers and the
Holders of Transfer Restricted Securities who are tendering Initial Securities
in the Registered Exchange Offer and/or selling or reselling Securities pursuant
to the "Plan of Distribution" contained in the Exchange Offer Registration
Statement or the Shelf Registration Statement, as applicable, for the reasonable
fees and disbursements of not more than one counsel, who shall be Latham &
Watkins unless another firm shall be chosen by the Holders of a majority in
principal amount of the Transfer Restricted Securities for whose benefit such
Registration Statement is being prepared.

       5.     Indemnification. (a) (a) The Company agrees to indemnify and hold
harmless each Holder of the Securities, any Participating Broker-Dealer and each
person, if any, who controls such Holder or such Participating Broker-Dealer
within the meaning of the Securities Act or the Exchange Act (each Holder, any
Participating Broker-Dealer and such controlling persons are referred to
collectively as the "Indemnified Parties") from and against any losses, claims,
damages or liabilities, joint or several, or any actions in respect thereof
(including, but not limited to, any losses, claims, damages, liabilities or
actions relating to purchases and sales of the Securities) to which each
Indemnified Party may become subject under the Securities Act, the Exchange Act
or otherwise, insofar as such losses, claims, damages, liabilities or actions
arise out of or are based upon any untrue statement or alleged untrue statement
of a material fact contained in a Registration Statement or prospectus or in any
amendment or supplement thereto or in any preliminary prospectus relating to a
Shelf Registration, or arise out of, or are based upon, the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, and shall reimburse, as
incurred, the Indemnified Parties for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss,
claim, damage, liability or action in respect thereof; provided, however, that
(i) the Company shall not be liable in any such case to the extent that such
loss, claim, damage or liability arises out of or is based upon any untrue
statement or alleged untrue statement or omission or alleged omission made in a
Registration Statement or prospectus or in any amendment or supplement thereto
or in any preliminary prospectus relating to a Shelf Registration in reliance
upon and in conformity with written information pertaining to such Holder and
furnished to the Company by or on behalf of such Holder specifically for
inclusion therein and (ii) with respect to any untrue statement or omission or
alleged untrue statement or omission made in any preliminary prospectus relating
to a Shelf Registration Statement, the indemnity agreement contained in this
subsection (a) shall not inure to the benefit of any Holder or Participating
Broker-Dealer from whom the person asserting any such losses, claims, damages or
liabilities purchased the Securities concerned, to the extent that a prospectus
relating to such Securities was required to be delivered by such Holder or
Participating Broker-Dealer under the Securities Act in connection with such
purchase and any such loss, claim, damage or liability of such Holder or
Participating Broker-Dealer results from the fact that there was not sent or
given to such person, at or prior to the written confirmation of the sale of
such Securities to such person, a copy of the amended, supplemented or final
prospectus if the Company had previously furnished copies thereof to such Holder
or Participating Broker-Dealer; provided further, however, that this indemnity
agreement will be in addition to any liability which the Company may otherwise
have to such Indemnified Party. The Company shall also indemnify underwriters,
their officers and directors and each person who controls such underwriters
within the meaning of the Securities Act or the Exchange Act to the

                          Registration Rights Agreement

<PAGE>

same extent as provided above with respect to the indemnification of the Holders
of the Securities if requested by such Holders.

              (b)    Each Holder of the Securities, severally and not jointly,
will indemnify and hold harmless (i) the Company and each person, if any, who
controls the Company within the meaning of the Securities Act or the Exchange
Act, (ii) each of their respective directors and (iii) each of their respective
officers who signs a Registration Statement from and against any losses, claims,
damages or liabilities or any actions in respect thereof, to which the Company
or any such controlling person, director or officer may become subject under the
Securities Act, the Exchange Act or otherwise, insofar as such losses, claims,
damages, liabilities or actions arise out of or are based upon any untrue
statement or alleged untrue statement of a material fact contained in a
Registration Statement or prospectus or in any amendment or supplement thereto
or in any preliminary prospectus relating to a Shelf Registration, or arise out
of or are based upon the omission or alleged omission to state therein a
material fact necessary to make the statements therein not misleading, but in
each case only to the extent that the untrue statement or omission or alleged
untrue statement or omission was made in reliance upon and in conformity with
written information pertaining to such Holder and furnished to the Company by or
on behalf of such Holder specifically for inclusion therein; and, subject to the
limitation set forth immediately preceding this clause, shall reimburse, as
incurred, the Company for any legal or other expenses reasonably incurred by the
Company or any such controlling person, director or officer in connection with
investigating or defending any loss, claim, damage, liability or action in
respect thereof. This indemnity agreement will be in addition to any liability
which such Holder may otherwise have to the Company or any of its controlling
persons, directors or officers.

              (c)    Promptly after receipt by an indemnified party under this
Section 5 of written notice of the commencement of any action or proceeding
(including a governmental investigation), such indemnified party will, if a
claim in respect thereof is to be made against the indemnifying party under this
Section 5, notify the indemnifying party of the commencement thereof; but the
omission so to notify the indemnifying party in writing will not, in any event,
relieve the indemnifying party from any obligations to any indemnified party
other than the indemnification obligation provided in paragraph (a) or (b)
above. In case any such action is brought against any indemnified party, and it
notifies the indemnifying party of the commencement thereof, the indemnifying
party will be entitled to participate therein and, to the extent that it may
elect by written notice, jointly with any other indemnifying party similarly
notified, to assume the defense thereof, with counsel reasonably satisfactory to
such indemnified party. After notice from the indemnifying party to such
indemnified party of its election so to assume the defense thereof the
indemnifying party will not be liable to such indemnified party under this
Section 5 for any legal or other expenses subsequently incurred by such
indemnified party in connection with the defense thereof other than reasonable
costs of investigation prior to assumption of defenses. No indemnifying party
shall, without the prior written consent of the indemnified party, effect any
settlement of any pending or threatened action in respect of which any
indemnified party is or could have been a party and indemnity could have been
sought hereunder by such indemnified party unless such settlement includes (i)
an unconditional release of such indemnified party from all liability on any
claims that are the subject matter of such action and (ii) does not include a
statement as to or an admission of fault, culpability or a failure to act by or
on behalf of any indemnified party.

                          Registration Rights Agreement

<PAGE>

              (d)    If the indemnification provided for in this Section 5 is
unavailable or insufficient to hold harmless an indemnified party under
subsections (a) or (b) above, then each indemnifying party shall contribute to
the amount paid or payable by such indemnified party as a result of the losses,
claims, damages or liabilities (or actions in respect thereof) referred to in
subsection (a) or (b) above (i) in such proportion as is appropriate to reflect
the relative benefits received by the indemnifying party or parties on the one
hand and the indemnified party on the other from the exchange of the Securities,
pursuant to the Registered Exchange Offer, or (ii) if the allocation provided by
the foregoing clause (i) is not permitted by applicable law, in such proportion
as is appropriate to reflect not only the relative benefits referred to in
clause (i) above but also the relative fault of the indemnifying party or
parties on the one hand and the indemnified party on the other in connection
with the statements or omissions that resulted in such losses, claims, damages
or liabilities (or actions in respect thereof) as well as any other relevant
equitable considerations. The relative fault of the parties shall be determined
by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Company on the one hand or
such Holder or such other indemnified party, as the case may be, on the other,
and the parties' relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The amount paid by
an indemnified party as a result of the losses, claims, damages or liabilities
referred to in the first sentence of this subsection (d) shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any action or claim which is
the subject of this subsection (d). Notwithstanding any other provision of this
Section 5(d), the Holders of the Securities shall not be required to contribute
any amount in excess of the amount by which the net proceeds received by such
Holders from the sale of the Securities pursuant to a Registration Statement
exceeds the amount of damages which such Holders have otherwise been required to
pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation. For purposes
of this paragraph (d), each person, if any, who controls such indemnified party
within the meaning of the Securities Act or the Exchange Act shall have the same
rights to contribution as such indemnified party and each person, if any, who
controls the Company within the meaning of the Securities Act or the Exchange
Act shall have the same rights to contribution as the Company.

              (e)    The agreements contained in this Section 5 shall survive
the sale of the Securities pursuant to a Registration Statement and shall remain
in full force and effect, regardless of any termination or cancellation of this
Agreement or any investigation made by or on behalf of any indemnified party.

       6.     Liquidated Damages Under Certain Circumstances.(a) Liquidated
damages (the "Liquidated Damages") with respect to the Securities shall be
assessed as follows if any of the following events occur (each such event in
clauses (i) through (iv) below being herein called a "Registration Default"):

                     (i)   any Registration Statement required by this Agreement
              is not filed with the Commission on or prior to the applicable
              Filing Deadline;

                          Registration Rights Agreement

<PAGE>

               (ii)   any Registration Statement required by this Agreement is
          not declared effective by the Commission on or prior to the applicable
          Effectiveness Deadline;

               (iii)  the Registered Exchange Offer has not been consummated on
          or prior to the Consummation Deadline; or

               (iv)   any Registration Statement required by this Agreement has
          been declared effective by the Commission but (A) such Registration
          Statement thereafter ceases to be effective or (B) such Registration
          Statement or the related prospectus ceases to be usable in connection
          with resales of Transfer Restricted Securities during the periods
          specified herein because either (1) any event occurs as a result of
          which the related prospectus forming part of such Registration
          Statement would include any untrue statement of a material fact or
          omit to state any material fact necessary to make the statements
          therein in the light of the circumstances under which they were made
          not misleading, or (2) it shall be necessary to amend such
          Registration Statement or supplement the related prospectus, to comply
          with the Securities Act or the Exchange Act or the respective rules
          thereunder.

Each of the foregoing will constitute a Registration Default whatever the reason
for any such event and whether it is voluntary or involuntary or is beyond the
control of the Company or pursuant to operation of law or as a result of any
action or inaction by the Commission.

     Liquidated Damages shall accrue on the Initial Securities and Private
Exchange Securities over and above the interest set forth in the title of the
Securities from and including the date on which any such Registration Default
shall occur to but excluding the date on which all such Registration Defaults
have been cured, at an amount equal to 0.25% per annum (the "Liquidated Damages
Rate") of the principal amount of notes for the first 90-day period immediately
following the occurrence of such Registration Default. The Liquidated Damages
Rate shall increase by an additional 0.25% per annum of the principal amount of
notes with respect to each subsequent 90-day period until all Registration
Defaults have been cured, up to a maximum Liquidated Damages Rate of 1.0% per
annum.

          (b)  A Registration Default referred to in Section 6(a)(iv) hereof
shall be deemed not to have occurred and be continuing in relation to a Shelf
Registration Statement or the related prospectus if (i) such Registration
Default has occurred solely as a result of (x) the filing of a post-effective
amendment to such Shelf Registration Statement to incorporate annual audited
financial information with respect to the Company where such post-effective
amendment is not yet effective and needs to be declared effective to permit
Holders to use the related prospectus or (y) other material events, with respect
to the Company that would need to be described in such Shelf Registration
Statement or the related prospectus and (ii) in the case of clause (y), the
Company is proceeding promptly and in good faith to amend or supplement such
Shelf Registration Statement and related prospectus to describe such events;
provided, however, that in any case if such Registration Default occurs for a
continuous period in excess of 30 days, Liquidated Damages shall be payable in
accordance with the above paragraph from the day such Registration Default
occurs until such Registration Default is cured.

                         Registration Rights Agreement

<PAGE>

          (c)  Any amounts of Liquidated Damages due pursuant to Section 6(a)
will be payable in cash on the regular interest payment dates with respect to
the Securities. The amount of Liquidated Damages will be determined by
multiplying the applicable Liquidated Damages Rate by the principal amount of
the Securities and further multiplied by a fraction, the numerator of which is
the number of days such Liquidated Damages Rate was applicable during such
period (determined on the basis of a 360-day year comprised of twelve 30-day
months), and the denominator of which is 360.

          (d)  "Transfer Restricted Securities" means each Security until (i)
the date on which such Security has been exchanged by a person other than a
broker-dealer for a freely transferable Exchange Security in the Registered
Exchange Offer, (ii) following the exchange by a broker-dealer in the Registered
Exchange Offer of an Initial Security for an Exchange Note, the date on which
such Exchange Note is sold to a purchaser who receives from such broker-dealer
on or prior to the date of such sale a copy of the prospectus contained in the
Exchange Offer Registration Statement, (iii) the date on which such Security has
been effectively registered under the Securities Act and disposed of in
accordance with the Shelf Registration Statement or (iv) the date on which such
Security is distributed to the public pursuant to Rule 144 under the Securities
Act or is saleable pursuant to Rule 144(k) under the Securities Act.

     7.   Rules 144 and 144A. The Company shall use its best efforts to file the
reports required to be filed by it under the Securities Act and the Exchange Act
in a timely manner and, if at any time the Company is not required to file such
reports, it will, upon the request of any Holder of Securities, make publicly
available other information so long as necessary to permit sales of their
securities pursuant to Rules 144 and 144A. The Company covenants that it will
take such further action as any Holder of Securities may reasonably request, all
to the extent required from time to time to enable such Holder to sell
Securities without registration under the Securities Act within the limitation
of the exemptions provided by Rules 144 and 144A (including the requirements of
Rule 144A(d)(4)). The Company will provide a copy of this Agreement to
prospective purchasers of Initial Securities identified to the Company by the
Initial Purchasers upon request. Upon the request of any Holder of Initial
Securities, the Company shall deliver to such Holder a written statement as to
whether it has complied with such requirements. Notwithstanding the foregoing,
nothing in this Section 7 shall be deemed to require the Company to register any
of its securities pursuant to the Exchange Act.

     8.   Underwritten Registrations. If any of the Transfer Restricted
Securities covered by any Shelf Registration are to be sold in an underwritten
offering, the investment banker or investment bankers and manager or managers
that will administer the offering ("Managing Underwriters") will be selected by
the Holders of a majority in aggregate principal amount of such Transfer
Restricted Securities to be included in such offering.

     No person may participate in any underwritten registration hereunder unless
such person (i) agrees to sell such person's Transfer Restricted Securities on
the basis reasonably provided in any underwriting arrangements approved by the
persons entitled hereunder to approve such arrangements and (ii) completes and
executes all questionnaires, powers of attorney, indemnities, underwriting
agreements and other documents reasonably required under the terms of such
underwriting arrangements.

                         Registration Rights Agreement

<PAGE>

     9.   Miscellaneous.

          (a)  Remedies. The Company acknowledges and agrees that any failure by
the Company to comply with its obligations under Section 1 and 2 hereof may
result in material irreparable injury to the Initial Purchasers or the Holders
for which there is no adequate remedy at law, that it will not be possible to
measure damages for such injuries precisely and that, in the event of any such
failure, the Initial Purchasers or any Holder may obtain such relief as may be
required to specifically enforce the Company's obligations under Sections 1 and
2 hereof. The Company further agrees to waive the defense in any action for
specific performance that a remedy at law would be adequate.

          (b)  No Inconsistent Agreements. The Company will not on or after the
date of this Agreement enter into any agreement with respect to its securities
that is inconsistent with the rights granted to the Holders in this Agreement or
otherwise conflicts with the provisions hereof. The rights granted to the
Holders hereunder do not in any way conflict with and are not inconsistent with
the rights granted to the holders of the Company's securities under any
agreement in effect on the date hereof.

          (c)  Amendments and Waivers. The provisions of this Agreement may not
be amended, modified or supplemented, and waivers or consents to departures from
the provisions hereof may not be given, except by the Company and the written
consent of the Holders of a majority in principal amount of the Securities
affected by such amendment, modification, supplement, waiver or consents.

          (d)  Notices. All notices and other communications provided for or
permitted hereunder shall be made in writing by hand delivery, first-class mail,
facsimile transmission, or air courier which guarantees overnight delivery:

               (1)    if to a Holder of the Securities, at the most current
          address given by such Holder to the Company.

               (2)    if to the Initial Purchasers;

                      Credit Suisse First Boston Corporation
                      Eleven Madison Avenue
                      New York, NY 10010-3629
                      Fax No.: (212) 325-8278
                      Attention: Transactions Advisory Group

               with a copy to:

                      Latham & Watkins
                      885 Third Avenue
                      New York, NY 10022
                      Fax No: (212) 751-4864
                      Attention: Kirk A. Davenport, Esq.

                         Registration Rights Agreement

<PAGE>

               (3)    if to the Company, at its address as follows:

                      AmerisourceBergen Corporation
                      1300 Morris Drive, Suite 100
                      Chesterbrook, PA 19087-5594
                      Fax No.: (610) 727-3600
                      Attention: William D. Sprague, Esq.

               with a copy to:

                      Dechert
                      4000 Bell Atlantic Tower
                      1717 Arch Street
                      Philadelphia, PA 19103-2793
                      Fax No.: (215) 994-2222
                      Attention: John D. LaRocca, Esq.

     All such notices and communications shall be deemed to have been duly
given: at the time delivered by hand, if personally delivered; three business
days after being deposited in the mail, postage prepaid, if mailed; when receipt
is acknowledged by recipient's facsimile machine operator, if sent by facsimile
transmission; and on the day delivered, if sent by overnight air courier
guaranteeing next day delivery.

          (e)  Third Party Beneficiaries. The Holders shall be third party
beneficiaries to the agreements made hereunder between the Company, on the one
hand, and the Initial Purchasers, on the other hand, and shall have the right to
enforce such agreements directly to the extent they may deem such enforcement
necessary or advisable to protect their rights or the rights of Holders
hereunder.

          (f)  Successors and Assigns. This Agreement shall be binding upon the
Company and its successors and assigns.

          (g) Counterparts. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

          (h)  Headings.  The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

          (i)  Governing Law.  THIS AGREEMENT SHALL BE GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD
TO PRINCIPLES OF CONFLICTS OF LAWS.

          (j)  Severability. If any one or more of the provisions contained
herein, or the application thereof in any circumstance, is held invalid, illegal
or unenforceable, the validity, legality and enforceability of any such
provision in every other respect and of the remaining provisions contained
herein shall not be affected or impaired thereby.

                         Registration Rights Agreement

<PAGE>

          (k)  Securities Held by the Company. Whenever the consent or approval
of Holders of a specified percentage of principal amount of Securities is
required hereunder, Securities held by the Company or its affiliates (other than
subsequent Holders of Securities if such subsequent Holders are deemed to be
affiliates solely by reason of their holdings of such Securities) shall not be
counted in determining whether such consent or approval was given by the Holders
of such required percentage.

                         Registration Rights Agreement

<PAGE>

     If the foregoing is in accordance with your understanding of our agreement,
please sign and return to the Issuer a counterpart hereof, whereupon this
instrument, along with all counterparts, will become a binding agreement among
the several Initial Purchasers, the Issuer and the Guarantors in accordance with
its terms.

                                Very truly yours,

                                AmerisourceBergen Corporation

                                         by: /s/ J.F. Quinn
                                             -----------------------------------
                                             Name:  J.F. Quinn
                                             Title: Vice President and Corporate
                                                    Treasurer

                                AmerisourceBergen Drug Corporation
                                AmerisourceBergen Services Corporation
                                AmeriSource Health Services Corporation
                                ASD Specialty Healthcare, Inc.
                                AutoMed Technologies, Inc.
                                Brownstone Pharmacy, Inc.
                                Capstone Pharmacy of Delaware, Inc.
                                Compuscript, Inc.
                                Computran Systems, Inc.
                                Dunnington Rx Services of Rhode Island, Inc.
                                Family Center Pharmacy, Inc.
                                Goot Nursing Home Pharmacy, Inc.
                                Health Services Capital Corporation
                                Insta-Care Pharmacy Services Corporation
                                ION, LLC
                                James Brudnick Company, Inc.
                                Medical Initiatives, Inc.
                                MediDyne Corp.
                                Pharmacy Corporation of America, Inc.
                                Pharmacy Corporation of America-Massachusetts,
                                Inc.
                                PharMerica Drug Systems, Inc.
                                PharMerica, Inc.
                                Premier Pharmacy, Inc.
                                Southwest Pharmacies, Inc.
                                The Lash Group, Inc.
                                Tmesys(TM), Inc.

                                         by: /s/ William D. Sprague
                                             -----------------------------------
                                             Name:  William D. Sprague
                                             Title: Vice President

<PAGE>

     If the foregoing is in accordance with your understanding of our agreement,
please sign and return to the Issuer a counterpart hereof, whereupon this
instrument, along with all counterparts, will become a binding agreement among
the several Initial Purchasers, the Issuer and the Guarantors in accordance with
its terms.

                                      Very truly yours,

                                      AmeriSource Heritage Corporation

                                             by: /s/ Daniel T. Hirst
                                                 -------------------------------
                                                 Name:  Daniel T. Hirst
                                                 Title: Vice President

                         Registration Rights Agreement

<PAGE>

The foregoing Registration
Rights Agreement is hereby confirmed
and accepted as of the date first
above written.

Credit Suisse First Boston Corporation
Banc of America Securities LLC
J.P. Morgan Securities Inc.
  as Representatives of the several Initial Purchasers

By: Credit Suisse First Boston Corporation

by: /s/ Ananth Bhogaraju
    --------------------------------
    Name:  Ananth Bhogaraju
    Title: Director

                         Registration Rights Agreement

<PAGE>

                                                                         ANNEX A

     Each broker-dealer that receives Exchange Securities for its own account
pursuant to the Exchange Offer must acknowledge that it will deliver a
prospectus in connection with any resale of such Exchange Securities. The Letter
of Transmittal states that by so acknowledging and by delivering a prospectus, a
broker-dealer will not be deemed to admit that it is an "underwriter" within the
meaning of the Securities Act. This Prospectus, as it may be amended or
supplemented from time to time, may be used by a broker-dealer in connection
with resales of Exchange Securities received in exchange for Initial Securities
where such Initial Securities were acquired by such broker-dealer as a result of
market-making activities or other trading activities. The Company has agreed
that, for a period of 180 days after the Expiration Date (as defined herein), it
will make this Prospectus available to any broker-dealer for use in connection
with any such resale. See "Plan of Distribution."

                                      A-1

<PAGE>

                                                                         ANNEX B

     Each broker-dealer that receives Exchange Securities for its own account in
exchange for Initial Securities, where such Initial Securities were acquired by
such broker-dealer as a result of market-making activities or other trading
activities, must acknowledge that it will deliver a prospectus in connection
with any resale of such Exchange Securities. See "Plan of Distribution."

                                      B-1

<PAGE>

                                                                         ANNEX C

                              PLAN OF DISTRIBUTION

     Each broker-dealer that receives Exchange Securities for its own account
pursuant to the Exchange Offer must acknowledge that it will deliver a
prospectus in connection with any resale of such Exchange Securities. This
Prospectus, as it may be amended or supplemented from time to time, may be used
by a broker-dealer in connection with resales of Exchange Securities received in
exchange for Initial Securities where such Initial Securities were acquired as a
result of market-making activities or other trading activities. The Company has
agreed that, for a period of 180 days after the Expiration Date, it will make
this prospectus, as amended or supplemented, available to any broker-dealer for
use in connection with any such resale. In addition, until          , 200[__],
all dealers effecting transactions in the Exchange Securities may be required to
deliver a prospectus./1/

     The Company will not receive any proceeds from any sale of Exchange
Securities by broker-dealers. Exchange Securities received by broker-dealers for
their own account pursuant to the Exchange Offer may be sold from time to time
in one or more transactions in the over-the-counter market, in negotiated
transactions, through the writing of options on the Exchange Securities or a
combination of such methods of resale, at market prices prevailing at the time
of resale, at prices related to such prevailing market prices or negotiated
prices. Any such resale may be made directly to purchasers or to or through
brokers or dealers who may receive compensation in the form of commissions or
concessions from any such broker-dealer or the purchasers of any such Exchange
Securities. Any broker-dealer that resells Exchange Securities that were
received by it for its own account pursuant to the Exchange Offer and any broker
or dealer that participates in a distribution of such Exchange Securities may be
deemed to be an "underwriter" within the meaning of the Securities Act and any
profit on any such resale of Exchange Securities and any commission or
concessions received by any such persons may be deemed to be underwriting
compensation under the Securities Act. The Letter of Transmittal states that, by
acknowledging that it will deliver and by delivering a prospectus, a
broker-dealer will not be deemed to admit that it is an "underwriter" within the
meaning of the Securities Act.

     For a period of 180 days after the Expiration Date the Company will
promptly send additional copies of this Prospectus and any amendment or
supplement to this Prospectus to any broker-dealer that requests such documents
in the Letter of Transmittal. The Company has agreed to pay all expenses
incident to the Exchange Offer (including the expenses of one counsel for the
Holders of the Securities) other than commissions or concessions of any brokers
or dealers and will indemnify the Holders of the Securities (including any
broker-dealers) against certain liabilities, including liabilities under the
Securities Act.

--------------------

/1/  In addition, the legend required by Item 502(e) of Regulation S-K will
     appear on the back cover page of the Exchange Offer prospectus.

                                      C-1

<PAGE>

                                                                         ANNEX D

[_]CHECK HERE IF YOU ARE A BROKER-DEALER AND WISH TO RECEIVE 10 ADDITIONAL
COPIES OF THE PROSPECTUS AND 10 COPIES OF ANY AMENDMENTS OR SUPPLEMENTS THERETO.

                  Name: ________________________________________________________
                  Address:  ____________________________________________________

     If the undersigned is not a broker-dealer, the undersigned represents that
it is not engaged in, and does not intend to engage in, a distribution of
Exchange Securities. If the undersigned is a broker-dealer that will receive
Exchange Securities for its own account in exchange for Initial Securities that
were acquired as a result of market-making activities or other trading
activities, it acknowledges that it will deliver a prospectus in connection with
any resale of such Exchange Securities; however, by so acknowledging and by
delivering a prospectus, the undersigned will not be deemed to admit that it is
an "underwriter" within the meaning of the Securities Act.

                                      D-1

<PAGE>

                                   SCHEDULE I
                                   Guarantors

AmerisourceBergen Drug Corporation
AmerisourceBergen Services Corporation
AmeriSource Health Services Corporation
AmeriSource Heritage Corporation
ASD Specialty Healthcare, Inc.
AutoMed Technologies, Inc.
Brownstone Pharmacy, Inc.
Capstone Pharmacy of Delaware, Inc.
Compuscript, Inc.
Computran Systems, Inc.
Dunnington Rx Services of Rhode Island, Inc.
Family Center Pharmacy, Inc.
Goot Nursing Home Pharmacy, Inc.
Health Services Capital Corporation
Insta-Care Pharmacy Services Corporation
ION, LLC
James Brudnick Company, Inc.
Medical Initiatives, Inc.
MediDyne Corp.
Pharmacy Corporation of America, Inc.
Pharmacy Corporation of America-Massachusetts, Inc.
PharMerica Drug Systems, Inc.
PharMerica, Inc.
Premier Pharmacy, Inc.
Southwest Pharmacies, Inc.
The Lash Group, Inc.
Tmesys(TM), Inc.

                         Registration Rights Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]